Perceptual disorders
MONDO:0024417Cognitive disorders characterized by an impaired ability to perceive the nature of objects or concepts through use of the sense organs. These include spatial neglect syndromes, where an individual does not attend to visual, auditory, or sensory stimuli presented from one side of the body.
2382 clinical trials for this condition and its sub-types, 22 tagged with Perceptual disorders itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Perceptual disorders
-
Agnosia 837 trials · 855 incl. sub-types
20 sub-types
- Pain agnosia 146 trials
- Alexithymia 10 trials
- Anosognosia 3 trials
- Visual agnosia 0 trials · 2 incl. sub-types Sub-types →
- Social emotional agnosia 1 trial
- Akinetopsia 0 trials
- Amusia 0 trials
- Astereognosia 0 trials
- Auditory agnosia 0 trials Sub-types →
- Autotopagnosia 0 trials
- Cortical deafness 0 trials
- Finger agnosia 0 trials
- Integrative agnosia 0 trials
- Mirror agnosia 0 trials
- Phonagnosia 0 trials
- Prosopagnosia 0 trials Sub-types →
- Semantic agnosia 0 trials
- Simultanagnosia 0 trials
- Tactile agnosia 0 trials
- Time agnosia 0 trials
-
Hearing disorder 24 trials · 529 incl. sub-types
4 sub-types
- Hearing loss disorder 299 trials · 439 incl. sub-types Sub-types →
- Tinnitus 90 trials
- Hyperacusis 10 trials Sub-types →
- Cortical deafness 0 trials
-
Inherited retinal dystrophy 41 trials · 510 incl. sub-types
105 sub-types
- Age-related macular degeneration 190 trials · 334 incl. sub-types Sub-types →
- Retinitis pigmentosa 84 trials · 89 incl. sub-types Sub-types →
- Hereditary macular dystrophy 3 trials · 70 incl. sub-types Sub-types →
- Cone-rod dystrophy 17 trials · 21 incl. sub-types Sub-types →
- Leber congenital amaurosis 10 trials · 12 incl. sub-types Sub-types →
- ABCA4-related retinopathy 7 trials · 11 incl. sub-types Sub-types →
- BEST1-related dominant retinopathy 1 trial · 7 incl. sub-types Sub-types →
- RHO-related retinopathy 0 trials · 7 incl. sub-types Sub-types →
- RPE65-related recessive retinopathy 5 trials · 7 incl. sub-types Sub-types →
- RPGR-related retinopathy 0 trials · 7 incl. sub-types Sub-types →
- Choroideremia 6 trials Sub-types →
- PRPF31-related retinopathy 1 trial · 4 incl. sub-types Sub-types →
- X-linked retinoschisis 4 trials
- Ornithine aminotransferase deficiency 4 trials
- ELOVL4-related maculopathy 0 trials · 3 incl. sub-types Sub-types →
- RLBP1-related retinopathy 2 trials · 3 incl. sub-types Sub-types →
- Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations 3 trials
- BEST1-related recessive retinopathy 0 trials · 2 incl. sub-types Sub-types →
- EYS-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- LCA5-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- PRPH2-related retinopathy 1 trial · 2 incl. sub-types Sub-types →
- Revesz syndrome 2 trials
- Late-onset retinal degeneration 2 trials
- AIPL1-related retinopathy 1 trial Sub-types →
- ATF6-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- CNGB1-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- FLVCR1-related retinopathy with or without ataxia 0 trials · 1 incl. sub-types Sub-types →
- GUCY2D retinopathy 0 trials · 1 incl. sub-types Sub-types →
- RDH5-related retinopathy 0 trials · 1 incl. sub-types Sub-types →
- Retinoschisis of fovea 1 trial
- ADAM9-related retinopathy 0 trials Sub-types →
- CACNA1F-related retinopathy 0 trials Sub-types →
- CACNA2D4-related retinopathy 0 trials Sub-types →
- CDHR1-related retinopathy 0 trials Sub-types →
- CERKL-related retinopathy 0 trials Sub-types →
- CNGA1-related retinopathy 0 trials Sub-types →
- CNGA3-related retinopathy 0 trials Sub-types →
- CRX-related retinopathy 0 trials Sub-types →
- GNAT2-related retinopathy 0 trials Sub-types →
- GPR179-related retinopathy 0 trials Sub-types →
- GRM6-related retinopathy 0 trials Sub-types →
- GUCA1A-related retinopathy 0 trials Sub-types →
- HGSNAT-related retinopathy 0 trials Sub-types →
- IDH3B-related retinopathy 0 trials Sub-types →
- IMPDH1-related retinopathy 0 trials Sub-types →
- IMPG1-related dominant retinopathy 0 trials Sub-types →
- IMPG1-related recessive retinopathy 0 trials Sub-types →
- IMPG2-related dominant retinopathy 0 trials Sub-types →
- IMPG2-related recessive retinopathy 0 trials Sub-types →
- KCNV2-related retinopathy 0 trials Sub-types →
- KIZ-related retinopathy 0 trials Sub-types →
- LRIT3-related retinopathy 0 trials Sub-types →
- MAK-related retinopathy 0 trials Sub-types →
- MERTK-related retinopathy 0 trials Sub-types →
- MRCS syndrome 0 trials
- NMNAT1-related retinopathy 0 trials Sub-types →
- NYX-related retinopathy 0 trials Sub-types →
- Oguchi disease 0 trials Sub-types →
- PCARE-related retinopathy 0 trials Sub-types →
- PDE6A-related retinopathy 0 trials Sub-types →
- PDE6C-related retinopathy 0 trials Sub-types →
- PDE6G-related retinopathy 0 trials Sub-types →
- PROM1-related retinopathy 0 trials Sub-types →
- PRPF8-related retinopathy 0 trials Sub-types →
- RAB28-related retinopathy 0 trials Sub-types →
- RD3-related retinopathy 0 trials Sub-types →
- RDH12-related dominant retinopathy 0 trials
- RDH12-related recessive retinopathy 0 trials Sub-types →
- REEP6-related retinopathy 0 trials Sub-types →
- RP1-related dominant retinopathy 0 trials
- RP1-related recessive retinopathy 0 trials
- RP2-related retinopathy 0 trials Sub-types →
- RPE65-related dominant retinopathy 0 trials Sub-types →
- SNRNP200-related dominant retinopathy 0 trials Sub-types →
- SPATA7-related retinopathy 0 trials Sub-types →
- Sorsby fundus dystrophy 0 trials Sub-types →
- TOPORS-related retinopathy 0 trials Sub-types →
- TRPM1-related retinopathy 0 trials Sub-types →
- TTLL5-related retinopathy 0 trials Sub-types →
- X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome 0 trials
- X-linked retinal dysplasia 0 trials
- Aceruloplasminemia 0 trials
- Amaurosis-hypertrichosis syndrome 0 trials
- Choroideremia-deafness-obesity syndrome 0 trials
- Dystrophies primarily involving the retinal pigment epithelium 0 trials
- Ectopia lentis-chorioretinal dystrophy-myopia syndrome 0 trials
- Familial benign flecked retina 0 trials
- Foveal hypoplasia-presenile cataract syndrome 0 trials
- Helicoid peripapillary chorioretinal degeneration 0 trials
- Infantile cerebellar-retinal degeneration 0 trials
- Macular degeneration, early-onset 0 trials
- Microcephaly and chorioretinopathy 1 0 trials
- Microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability 0 trials
- Microcornea-myopic chorioretinal atrophy 0 trials
- Oligocone trichromacy 0 trials
- Pigmented paravenous retinochoroidal atrophy 0 trials
- Progressive bifocal chorioretinal atrophy 0 trials
- Progressive retinal dystrophy due to retinol transport defect 0 trials
- Retinal degeneration-nanophthalmos-glaucoma syndrome 0 trials
- Retinal dystrophies primarily involving Bruch's membrane 0 trials Sub-types →
- Retinal dystrophy in systemic or cerebroretinal lipidoses 0 trials
- Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies 0 trials
- Retinal dystrophy, X-linked, Gardner-Hardcastle type 0 trials
- Retinoschisis, autosomal dominant 0 trials
- Vitreoretinal dystrophy 0 trials
-
Vision disorder 105 trials · 382 incl. sub-types
7 sub-types
- Visual pathway disorder 1 trial · 201 incl. sub-types Sub-types →
- Blindness (disorder) 38 trials · 80 incl. sub-types Sub-types →
- Amblyopia 38 trials · 39 incl. sub-types Sub-types →
- Color vision disorder 3 trials · 15 incl. sub-types Sub-types →
- Binocular vision disease 4 trials Sub-types →
- Visual agnosia 0 trials · 2 incl. sub-types Sub-types →
- Alice in Wonderland syndrome 0 trials
-
Vestibular disorder 64 trials · 92 incl. sub-types
1 sub-type
- Peripheral vertigo 2 trials · 34 incl. sub-types Sub-types →
-
Apraxia 17 trials · 40 incl. sub-types
2 sub-types
- Gait apraxia 23 trials
- Ideomotor apraxia 0 trials
-
Auditory perceptual disorders 12 trials · 22 incl. sub-types
1 sub-type
- Hyperacusis 10 trials Sub-types →
-
Allesthesia 1 trial
Most studied deeper sub-types
-
Can a single injection save sight in a rare retinal disease?
Cure OngoingThis early-stage trial is testing whether a gene therapy called NGGT001, injected under the retina, is safe and tolerable for people with Bietti's crystalline dystrophy, a rare inherited condition that causes progressive vision loss. The study enrolls about 11 adults with a confi…
Early phase 1 • Sponsor: Xiamen Ophthalmology Center Affiliated to Xiamen University • Aim: Cure
Last updated Aug 19, 2026 00:00 UTC
-
Can a gene therapy restore natural hearing after cochlear implants?
Cure OngoingThis trial tests an experimental gene therapy called EA0010 in children aged 1 to 17 with hearing loss caused by mutations in the OTOF gene, who already have cochlear implants. The therapy is injected into one ear and aims to deliver a working copy of the OTOF gene to inner ear c…
Sponsor: Shanghai EmayGene Technology Co., Ltd • Aim: Cure
Last updated Aug 14, 2026 00:00 UTC
-
Can a single injection restore sight in a rare genetic eye disease?
Cure OngoingThis trial tests an experimental gene therapy called NGGT001 for people with Bietti Crystalline Dystrophy, a rare inherited condition that causes progressive vision loss. The therapy is delivered as a single injection under the retina, aiming to replace a faulty gene with a worki…
Phase 1/2 • Sponsor: NGGT (Suzhou) Biotechnology Co., Ltd. • Aim: Cure
Last updated Aug 14, 2026 00:00 UTC
-
Can a single injection restore sight in a rare childhood blindness?
Cure OngoingThis trial tests a gene therapy called ATSN-101, given as a one-time injection under the retina, for people with Leber congenital amaurosis caused by GUCY2D gene mutations. The goal is to see if the treatment is safe and can improve vision. Participants receive the therapy in one…
Phase 1/2 • Sponsor: Atsena Therapeutics Inc. • Aim: Cure
Last updated Aug 05, 2026 00:00 UTC
-
Can a single eye injection restore sight in genetic blindness?
Cure OngoingThis trial tests an experimental gene therapy called OCU400 in people with retinitis pigmentosa or Leber congenital amaurosis, which are inherited conditions that cause progressive vision loss and can lead to blindness. The therapy is given as a single injection into the eye, wit…
Phase 1/2 • Sponsor: Ocugen • Aim: Cure
Last updated Aug 02, 2026 00:00 UTC
-
One-Time injection aims to restore hearing in children born deaf
Cure OngoingThis trial tests a gene therapy called SENS-501 for children aged 6 to 31 months who are severely or profoundly deaf due to mutations in the otoferlin gene. The therapy is injected directly into one inner ear to deliver a working copy of the gene. The goal is to restore natural h…
Phase 1/2 • Sponsor: Sensorion • Aim: Cure
Last updated Jul 10, 2026 00:00 UTC
-
Higher-Dose eye injection shows promise for two leading causes of vision loss
Disease control OngoingThis study tests a higher dose of the drug aflibercept (8 mg) given as an eye injection every 4 weeks to people with wet age-related macular degeneration (nAMD) or diabetic macular edema (DME). The goal is to see if this dosing schedule is safe and works well for those who have a…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New hope for dravet syndrome: phase 3 trial of LP352 aims to cut seizure frequency
Disease control OngoingThis study tests whether the drug LP352 can safely reduce seizures in children and adults with Dravet syndrome, a severe form of epilepsy. About 160 participants will receive either LP352 or a placebo, and researchers will track changes in seizure frequency over several months. T…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a daily injection save your sight? new trial for dry AMD
Disease control OngoingThis phase 3 trial tests whether a daily injection of elamipretide can slow vision loss in people with dry age-related macular degeneration (AMD). About 313 adults aged 55 and older with early dry AMD will receive either the drug or a placebo for 96 weeks. The main goal is to see…
Phase 3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for hard-to-treat lung cancer: experimental drug targets MET gene
Disease control OngoingThis study tests an experimental drug called REGN5093 in people with advanced non-small cell lung cancer that has a specific change in the MET gene. The first part finds a safe dose, and the second part checks if the drug can shrink tumors. About 231 participants will take part.
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Hard-to-Treat seizures: phase 3 trial launches
Disease control OngoingThis study tests an experimental drug called LP352 to see if it can safely reduce seizures in children and adults with developmental and epileptic encephalopathies (DEE), a group of severe epilepsy syndromes. About 320 participants will receive either LP352 or a placebo, and rese…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Brain implant shows promise for Hard-to-Treat seizures in rare epilepsy
Disease control OngoingThis study tests a brain-responsive neurostimulation system in 24 people aged 12 and older with Lennox-Gastaut syndrome whose seizures are not controlled by medication. The device detects and responds to seizure activity in the brain to reduce drop seizures. The goal is to see if…
Phase 2 • Sponsor: NeuroPace • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New proton therapy aims to shield memory in kids with brain cancer
Disease control OngoingThis study tests a new way to give proton radiation to children with low-grade glioma, a common brain tumor. The goal is to avoid the hippocampus, a brain area key for memory, to reduce long-term memory loss. About 74 children will receive this targeted radiation, and researchers…
Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New gene therapy aims to fix immune system in rare disease
Disease control By invitation onlyThis study tests a new gene therapy for people with chronic granulomatous disease (CGD), a genetic disorder that weakens the immune system and makes them prone to serious infections. The treatment takes the patient's own blood stem cells, adds a missing gene in the lab, and puts …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New drug LP352 aims to control seizures in severe epilepsy over the long term
Disease control By invitation onlyThis phase 3 study is testing the long-term safety and effectiveness of LP352 (Bexicaserin) in 324 children and adults with developmental and epileptic encephalopathy (DEE), including Dravet and Lennox-Gastaut syndromes. Participants who completed earlier studies will receive LP3…
Phase 3 • Sponsor: Longboard Pharmaceuticals • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New epilepsy drug XEN1101 tested for long-term seizure control
Disease control By invitation onlyThis study tests the long-term safety and effectiveness of XEN1101 (azetukalner) in 880 adults with focal or tonic-clonic seizures. Participants who completed earlier studies will take XEN1101 capsules for up to 6 years. Researchers will track side effects and changes in monthly …
Phase 3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New eye injection aims to slow vision loss from Age-Related macular degeneration
Disease control OngoingThis study tests the safety of a drug called ASP3021 (avacincaptad pegol) for people in Japan with geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. Twenty participants will receive monthly injections into the affected eye for 12 mo…
Phase 4 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Gene therapy shot could end frequent eye injections for wet AMD
Disease control OngoingThis early-stage trial tests a one-time gene therapy injection (NG101) for wet age-related macular degeneration. The therapy uses a harmless virus to deliver a gene that makes a drug inside the eye, aiming to reduce the need for repeated anti-VEGF injections. About 20 adults aged…
Phase 1/2 • Sponsor: Elisigen, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for kids with focal seizures: cenobamate trial underway
Disease control OngoingThis phase 3 trial is testing the safety and tolerability of the drug cenobamate (Xcopri) in 140 children aged 2 to 17 with partial-onset (focal) seizures. Researchers will monitor side effects, lab results, and drug levels in the blood. The study is open-label, meaning everyone …
Phase 3 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Keto diet for epilepsy: heart risks under the microscope
Disease control OngoingThis study looks at how ketogenic diets impact heart health in adults with epilepsy. Researchers will measure cholesterol, blood pressure, weight, and artery thickness over 12 months. Participants are adults 18 or older who are already on a keto diet or starting the modified Atki…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Invisible hearing: new implant hides under the skin
Disease control OngoingThis study tests a new type of cochlear implant that is completely hidden under the skin, with no external processor. It is designed for adults with severe hearing loss who do not get enough benefit from hearing aids. The implant picks up sound through a microphone under the skin…
Sponsor: Cochlear • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New eye drug could slash injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 participants will receive either EYP-1901 or the standard drug aflibercept. The goal is to see if EYP-1901 can maintain or…
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New eye drug aims to cut injection frequency for wet AMD patients
Disease control OngoingThis phase 3 trial tests EYP-1901, a new eye injection that may last longer than current treatments for wet age-related macular degeneration (AMD). About 400 people with wet AMD will receive either EYP-1901 or standard aflibercept injections over 2 years. The main goal is to see …
Phase 3 • Sponsor: EyePoint Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Eye implant could replace monthly shots for blinding disease
Disease control OngoingThis study tests a small, refillable implant placed in the eye that slowly releases medication for wet age-related macular degeneration (nAMD). It aims to see if refilling the implant every 24 weeks works as well as getting a standard eye injection every 4 weeks. About 68 Chinese…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy targets second eye in rare blindness disorder
Disease control OngoingThis study tests a gene therapy called botaretigene sparoparvovec in the second eye of people with X-linked retinitis pigmentosa, a genetic condition that causes vision loss. The 24 participants previously received the therapy in one eye and are now being followed for safety and …
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Gene therapy shows promise for rare blindness disease
Disease control OngoingThis study is a follow-up to a Phase 3 trial testing a gene therapy called AAV5-hRKp.RPGR for people with X-linked retinitis pigmentosa, a genetic eye disease that causes vision loss. The treatment aims to slow or stop vision decline by delivering a working copy of the RPGR gene …
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Experimental gene therapy aims to halt vision loss in rare eye disease
Disease control OngoingThis Phase 3 study tests a gene therapy called AAV5-hRKp.RPGR in 4 Japanese people with X-linked retinitis pigmentosa, a genetic condition that causes progressive vision loss. The therapy is injected into the eye to deliver a working copy of the RPGR gene. The main goal is to che…
Phase 3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a tiny implant replace monthly eye shots for wet AMD?
Disease control OngoingThis study tests an experimental implant (AR-14034) that slowly releases medication inside the eye to treat wet age-related macular degeneration (AMD). The goal is to see if it is safe and can work as well as or better than standard anti-VEGF injections, which require frequent do…
Phase 1/2 • Sponsor: Alcon Research • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New epilepsy drug tested as standalone treatment
Disease control OngoingThis study tests whether cenobamate, already approved for epilepsy, works well when used alone in adults with partial-onset seizures. About 49 participants will take either 100 mg or 200 mg daily, and researchers will track how many become seizure-free for 26 weeks. The goal is t…
Phase 4 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a One-Time gene injection slow inherited blindness?
Disease control OngoingThis study follows patients with Stargardt's macular degeneration, an inherited eye disease that causes progressive vision loss, who previously received an experimental gene therapy called SAR422459. The goal is to check the long-term safety and tolerability of the treatment and …
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Video games vs eye patches: a new hope for lazy eye?
Disease control OngoingThis trial tests whether playing binocular iPad games can improve vision in children with amblyopia (lazy eye) better than the standard treatment of patching. Children aged 4-14 with amblyopia will either play the games or wear a patch, and their visual acuity and eye coordinatio…
Sponsor: Retina Foundation of the Southwest • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Experimental drug combo tested for rare, deadly castleman disease
Disease control OngoingThis study looks at a rare disease called KSHV-associated multicentric Castleman's disease (MCD), caused by a virus. Researchers are testing several drug combinations, including chemotherapy and antivirals, to see if they can control the disease. The study also tracks how the dis…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Drug shows promise for Long-Term seizure control in rare disease
Disease control OngoingThis study looks at the long-term safety of everolimus in people with tuberous sclerosis complex (TSC) who have seizures that are hard to control. Participants are already taking everolimus and benefiting from it in an earlier study. The goal is to see if the drug remains safe an…
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Rapamycin drug tested for rare castleman disease
Disease control OngoingThis phase 2 study tests the drug sirolimus (rapamycin) in 7 people with idiopathic multicentric Castleman disease who have not improved with standard therapy. The goal is to see if sirolimus can improve symptoms like fatigue, fever, and night sweats, and shrink enlarged lymph no…
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a booster session boost chronic pain relief?
Disease control OngoingThis trial investigates whether adding a booster session and extended access to the rehabilitation team after standard interdisciplinary care can improve outcomes for people with chronic pain. Two hundred participants in Swedish primary healthcare will be randomly assigned to eit…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a One-Time gene therapy preserve sight for years? a 15-Year study aims to find out
Disease control OngoingThis study follows people who previously received a one-time gene therapy injection for a rare inherited eye disease caused by RPE65 mutations. Researchers will test vision and light sensitivity over up to 15 years to see how well the treatment holds up. The goal is to understand…
Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New implant could help deaf children hear without traditional aids
Disease control OngoingThis study is testing a device called the BONEBRIDGE, a bone conduction implant that helps people with certain types of hearing loss hear better. The implant is placed under the skin behind the ear during surgery and works by sending sound vibrations through the skull bone direct…
Sponsor: Med-El Corporation • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a common diabetes drug protect eyesight in stargardt disease?
Disease control OngoingThis study tests whether metformin, a widely used diabetes drug, can safely slow vision loss in people with ABCA4 retinopathy (Stargardt disease). Fifty-five participants aged 12 and older will take metformin by mouth for 24 months, with regular eye exams to track changes. The go…
Phase 1/2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New eye injection aims to halt vision loss in dry AMD
Disease control OngoingThis early-stage trial is testing a new drug called VOY-101 for people with advanced dry age-related macular degeneration (AMD) and geographic atrophy, a condition that causes blind spots. The drug is injected into the eye and aims to slow damage to the retina and preserve vision…
Phase 1/2 • Sponsor: Perceive Biotherapeutics, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New hearing implant trial aims to help kids hear better
Disease control OngoingThis study tests the Sentio bone-anchored hearing system in 50 children aged 3 to 11 with hearing loss or single-sided deafness. The device is already approved for older kids and adults. Researchers want to see if it safely improves hearing compared to no aid. The trial is happen…
Sponsor: Oticon Medical • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for kids with NF1 brain tumors: targeted drug may beat chemo
Disease control OngoingThis study compares a targeted drug called selumetinib to standard chemotherapy (carboplatin/vincristine) in children aged 2 to 21 with neurofibromatosis type 1 (NF1) and low-grade glioma, a type of brain tumor. The goal is to see if selumetinib works as well or better at control…
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New pill aims to tame seizures in Drug-Resistant epilepsy
Disease control OngoingThis study tests whether a daily pill called BHV-7000 can reduce seizures in adults with refractory focal epilepsy—a type of epilepsy that doesn't respond well to current medications. About 390 participants will receive either a low dose, a higher dose, or a placebo for 8 weeks. …
Phase 2/3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can an antioxidant slow vision loss? new trial tests NAC for retinitis pigmentosa
Disease control OngoingThis study is testing the long-term safety of a high-dose antioxidant called N-Acetylcysteine (NAC) in 30 adults with retinitis pigmentosa, an inherited eye disease that causes gradual vision loss and blindness. Participants take 1800 mg of NAC twice daily for two years, with reg…
Phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a parasite drug fight childhood brain tumors?
Disease control OngoingThis trial is testing whether mebendazole, a drug commonly used to treat intestinal parasites, can help children with brain tumors called gliomas. The study combines mebendazole with standard chemotherapy drugs to see if it is safe and effective. It includes children and young ad…
Phase 1/2 • Sponsor: Julie Krystal • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a One-Time gene therapy tame wet AMD for years?
Disease control By invitation onlyThis study follows people who previously received an experimental gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see how safe and effective the treatment remains over up to five years after the injection.…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
One-Shot gene therapy could end monthly eye injections for wet AMD
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. About 714 adults aged 50-89 who currently need regular eye injections will receive either the gene therapy or standard treatment. The goal is to…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New epilepsy drug vormatrigine tested for Long-Term safety in 700 adults
Disease control By invitation onlyThis study is testing the long-term safety of a once-daily drug called vormatrigine in 700 adults with focal or generalized tonic-clonic seizures. Participants must have already taken vormatrigine in a previous trial or program. The main goal is to check for side effects and chan…
Phase 3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New eye implant could cut treatment visits to twice a year for wet AMD
Disease control OngoingThis phase 3 trial tests whether a refillable eye implant delivering ranibizumab can be safely used every 36 weeks instead of every 24 weeks for people with wet age-related macular degeneration. About 451 participants who have already responded to standard injections will receive…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New eye drug could cut wet AMD shots to just twice a year
Disease control OngoingThis study tests whether faricimab, an already-approved eye injection, can be given every 24 weeks (about twice a year) to people newly diagnosed with wet age-related macular degeneration (AMD). The trial involves 274 participants and will measure how well vision is maintained ov…
Phase 4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene therapy trial aims to restore night vision in rare eye disease
Disease control OngoingThis study tests a gene therapy called OCU400 for people with retinitis pigmentosa, an inherited eye disease that causes vision loss. The treatment is injected under the retina to help light-sensitive cells work better. The trial enrolled 140 people aged 3 and older and measures …
Phase 3 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene therapy trial aims to halt blindness in dry AMD
Disease control OngoingThis study tests a gene therapy called OCU410 for geographic atrophy, a severe form of dry age-related macular degeneration that causes vision loss. About 60 adults aged 50 and older will receive a single injection of OCU410 into the eye. Researchers will monitor safety and check…
Phase 1/2 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Gene therapy slows vision loss in stargardt disease trial
Disease control OngoingThis study tests a new gene therapy called OCU410ST for people with Stargardt disease, an inherited eye condition that causes vision loss. Early results show the treatment slowed damage to the retina by nearly half and improved or stabilized eyesight in all treated patients. The …
Phase 2/3 • Sponsor: Ocugen • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Cell injection aims to slow vision loss in rare eye disease
Disease control OngoingThis study tests the safety of a single injection of jCell (retinal progenitor cells) into the eye for people with retinitis pigmentosa, a genetic condition that causes vision loss. Sixty adults will receive either the active treatment or a sham injection, and researchers will mo…
Phase 2 • Sponsor: jCyte, Inc • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a donor lens implant restore clarity to clouded corneas?
Disease control By invitation onlyThis trial investigates whether implanting a fresh corneal lenticule — a thin layer of donor cornea taken from myopic patients — can improve transparency and vision in people with macular corneal dystrophy, a condition that clouds the cornea. Using a femtosecond laser, surgeons r…
Sponsor: Eye Hospital Pristina Kosovo • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a common sedative boost survival after cancer surgery in seniors?
Disease control OngoingThis study looked at whether adding dexmedetomidine to standard morphine pain relief after cancer surgery helps elderly patients (65-90 years) live longer. 1,500 participants were randomly assigned to receive either morphine alone or morphine plus dexmedetomidine for three days a…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug aims to slow vision loss in Age-Related blindness
Disease control OngoingThis study tests a drug called BI 1584862 in 150 adults aged 50+ with geographic atrophy, an advanced form of age-related macular degeneration that causes blind spots. Participants receive either the drug or a placebo for 1 year. Doctors track changes in the retina using special …
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Alga supplement could boost sight in rare eye disease
Disease control By invitation onlyThis study tests whether a natural supplement from Dunaliella alga, rich in 9-cis beta-carotene, can improve vision in adults with retinitis pigmentosa. Forty-one participants will take the supplement or a placebo for 3 months, then switch after a 6-month break. Researchers will …
Phase 1/2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Stem cells injected into eye aim to halt blindness
Disease control OngoingThis study tests a stem cell therapy called OpRegen for people with advanced dry age-related macular degeneration (geographic atrophy). Researchers inject retinal pigment epithelium cells derived from human embryonic stem cells into the eye to see if they can safely replace damag…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Hearing aids may slow memory loss in seniors, major trial hopes
Disease control OngoingThis study follows 629 older adults for 3 years to see if using hearing aids and getting hearing rehab can slow down memory loss and lower the risk of dementia. Participants were already in an earlier trial and now continue with hearing care or a delayed treatment. The goal is to…
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Magnetic pulses to the brain may restore vision in adult lazy eye
Disease control OngoingThis study tests whether a non-invasive brain stimulation technique called theta burst transcranial magnetic stimulation (TBS) can improve vision in adults with amblyopia, or lazy eye. Amblyopia affects about 3% of adults and currently has no effective treatment after childhood. …
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Single shot could replace monthly eye injections for wet AMD
Disease control OngoingThis study tests a new drug called SAR402663, given as a single injection into the eye, for people with wet age-related macular degeneration (AMD). The goal is to see if one dose can safely control the disease and reduce the need for frequent anti-VEGF injections. About 66 partic…
Phase 1/2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could stem cell secretions protect hearing during implant surgery?
Disease control OngoingThis early-stage trial tests whether a substance called VSF1.01, made from stem cell secretions, can safely reduce trauma to the inner ear during cochlear implant surgery. Eleven adults with severe hearing loss will receive the treatment directly into the cochlea before the impla…
Phase 1/2 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Gene therapy for ear tumors: Long-Term safety under review
Disease control By invitation onlyThis study follows 100 people with vestibular schwannoma (a non-cancerous ear tumor) who previously received a gene therapy called AAVAnc80-antiVEGF. Researchers will monitor for late side effects and measure tumor size changes over time using MRI scans. The goal is to understand…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Hope for Meniere's sufferers: new drug enters final testing phase
Disease control OngoingThis study tests a drug called SPI-1005 in 200 adults with Meniere's disease, a condition that causes hearing loss, ringing in the ears, and dizziness. Participants will take the drug twice a day for 6 or 12 months to see if it is safe and tolerable. The goal is to find a treatme…
Phase 3 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New epilepsy drug shows promise for kids in early trial
Disease control OngoingThis study tests whether adding perampanel (Fycompa) to current epilepsy medications can reduce seizures in children aged 1 month to 18 years. About 100 children with specific epilepsy syndromes or partial-onset seizures will receive the drug. The main goal is to see if at least …
Phase 2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New eye injection aims to slow blindness in rare genetic disease
Disease control OngoingThis study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A). The drug is injected into the eye and may help slow vision loss. The trial involves 81 participants, some of whom will receive a sham (fake) in…
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a home eye scanner replace frequent doctor visits for wet AMD?
Disease control OngoingThis Phase 3 trial tests whether people with wet age-related macular degeneration can use a home optical coherence tomography (OCT) device to guide when they need eye injections, instead of following a fixed schedule. 600 participants will either receive faricimab injections on a…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Stem cell eye transplant aims to halt blindness from rare genetic disease
Disease control OngoingThis study tests whether transplanting lab-grown retinal cells (derived from human embryonic stem cells) into the back of the eye can safely slow or improve vision loss in people with retinitis pigmentosa, a genetic condition that causes gradual blindness. Participants must have …
Phase 1 • Sponsor: Qi Zhou • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a blood extract save sight? early trial tests PRP for rare eye diseases
Disease control OngoingThis pilot study tests whether injections of platelet-rich plasma (PRP) made from a patient's own blood can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants receive three injections over four months, and researchers …
Phase 1/2 • Sponsor: Rubens Camargo Siqueira • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can an arthritis drug save sight? small trial tests adalimumab for rare eye diseases
Disease control OngoingThis pilot study tests whether adalimumab, an anti-inflammatory drug, can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants will receive three injections into the eye over four months. The main goal is to see if the t…
Phase 1/2 • Sponsor: Centro de Pesquisa Rubens Siqueira • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Gene therapy shot into both eyes aims to save sight in rare blindness
Disease control OngoingThis study tests a gene therapy called laruparetigene zovaparvovec (AGTC-501) in 10 males aged 12-50 with X-linked retinitis pigmentosa, a genetic condition that leads to vision loss. The therapy is injected into both eyes to deliver a working copy of the RPGR gene. The main goal…
Phase 2 • Sponsor: Beacon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
One-Time gene injection aims to halt rare eye disease
Disease control OngoingThis study tests a single injection of ZVS101e, a gene therapy that delivers a working copy of the CYP4V2 gene directly into the retina. It is for adults with Bietti's crystalline dystrophy, a rare inherited condition that leads to progressive vision loss. The trial will check wh…
Phase 1/2 • Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Gene therapy injection aims to restore sight in rare eye disease
Disease control OngoingThis study tests a single injection of ZVS101e gene therapy for people with Bietti's crystalline dystrophy, a rare inherited condition that leads to progressive vision loss. The therapy delivers a working copy of the CYP4V2 gene directly to the retina. Researchers will measure wh…
Phase 3 • Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental gene therapy offers hope for rare blindness condition
Disease control By invitation onlyThis study provides ZVS101e, a gene therapy, to 32 people with Bietti crystalline corneoretinal dystrophy (BCD) who were in the control group of a previous Phase III trial. The therapy uses a harmless virus to deliver a working gene to the eye, aiming to slow vision loss. The mai…
Sponsor: Chigenovo Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Antioxidant pill shows promise in slowing blindness
Disease control OngoingThis phase 3 trial tests whether an oral antioxidant called N-acetylcysteine (NAC) can slow the loss of vision in people with retinitis pigmentosa, an inherited eye disease that causes gradual blindness. About 485 adults aged 18 to 65 are taking NAC or a placebo for several years…
Phase 3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Real-World study tracks Epidyolex's Long-Term impact on seizures
Disease control OngoingThis study follows 158 people in France who are prescribed Epidyolex (a cannabidiol-based medicine) for seizures as part of their normal care. Researchers will track how long people stay on the treatment, side effects, seizure frequency, and changes in daily functioning and quali…
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with resistant tumors: drug combo enters safety trial
Disease control OngoingThis early-stage study tests a combination of two drugs, avutometinib and defactinib, in children and young adults (ages 3 to 30) with advanced or recurrent solid tumors that have specific genetic changes. The main goal is to find the safest dose with the fewest side effects. The…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain implant study tests new epilepsy drug
Disease control OngoingThis early-phase study tested a new drug called BHV-7000 in 5 people with epilepsy who have a brain implant (RNS) that records brain activity. The goal was to see if the drug reduces abnormal electrical activity linked to seizures. Participants took the drug for 4 weeks, and thei…
Phase 1 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Surgery vs. diet: which tames diabetes better?
Disease control OngoingThis study compares two types of weight-loss surgery (gastric bypass and gastric banding) with an intensive diet and exercise program for controlling type 2 diabetes in moderately obese adults aged 25 to 55. The goal is to see which approach works best for improving diabetes and …
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
CBD epilepsy drug under Real-World watch for rare seizure disorders
Disease control OngoingThis study follows about 111 people with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex who are taking Epidyolex (a CBD oral solution) for seizures. Researchers track how many stay on the drug for a year and how many seizure-free days they have. It's an o…
Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Bionic eye implant aims to bring back sight in advanced macular degeneration
Disease control OngoingThis study tests a device called the PRIMA System, which includes an implant placed under the retina and a special visual processor worn by the patient. The goal is to help people with advanced dry age-related macular degeneration (geographic atrophy) regain some central vision. …
Sponsor: Science Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
One shot to save sight? gene therapy aims to cut eye injections for wet AMD
Disease control OngoingThis phase 3 trial tests a single injection of 4D-150 gene therapy in 480 adults with wet age-related macular degeneration (AMD). The goal is to see if one treatment can control the disease as well as or better than standard aflibercept injections given every few weeks. Participa…
Phase 3 • Sponsor: 4D Molecular Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Syfovre safety check: Real-World study tracks eye drug in 300 patients
Disease control OngoingThis study looks at how safe and tolerable the drug pegcetacoplan (Syfovre) is for people with geographic atrophy, a form of advanced age-related macular degeneration that causes vision loss. About 300 patients who are already prescribed the drug by their doctor will be followed …
Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental eye drug shows promise for rare Blindness-Causing disease
Disease control OngoingThis study tests an experimental drug called VP-001 for people with a rare genetic eye disease that causes vision loss. The drug is injected into the eye and aims to slow or stop further damage. Researchers will check safety and measure any changes in eyesight over about two year…
Phase 1/2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Invisible hearing: new cochlear implant needs no external parts
Disease control OngoingThis study tests a new totally implantable cochlear implant system (TICI G2) that has a microphone under the skin, so you can hear without any external devices. Researchers will enroll 18 adults with sensorineural hearing loss to see how well the internal microphone works over ti…
Sponsor: Cochlear • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy shot could end monthly eye injections for wet AMD
Disease control OngoingThis Phase 3 trial tests a single injection of Ixo-vec gene therapy in 311 people with wet age-related macular degeneration (AMD). The goal is to see if it can maintain or improve vision as well as standard aflibercept injections, but with fewer follow-up treatments. Participants…
Phase 3 • Sponsor: Adverum Biotechnologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Hearing loss injection study pulled before it began
Disease control CancelledThis pilot study aimed to test whether a mixture of dexamethasone, hyaluronic acid, and a green dye could be safely injected into the ear to treat certain types of hearing loss that don't improve with standard treatments. The plan was to enroll 26 adults with sudden hearing loss,…
Phase 1/2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
One-Patient trial hopes to slow rare eye and nerve disease
Disease control By invitation onlyThis early-phase trial tests an experimental drug called nL-FLVC-001 in a single person with posterior column ataxia with retinitis pigmentosa (PCARP), a rare genetic condition that causes vision loss and coordination problems. The drug is an antisense oligonucleotide injected in…
Early phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Telescope eye implant study for AMD withdrawn before it began
Disease control CancelledThis study planned to test a small telescope implant inside the eye for people with severe vision loss from advanced age-related macular degeneration (AMD). The device was meant to improve central vision by magnifying images onto healthy parts of the retina. However, the trial wa…
Sponsor: VisionCare, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a cochlear implant bring back hearing after tumor removal?
Disease control OngoingThis study tests whether a cochlear implant can safely and effectively restore hearing in people who become deaf in one ear after surgery to remove a benign tumor (vestibular schwannoma) or to treat Meniere's disease. Fifteen participants will receive the implant during their sur…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for kids with tough brain tumors: targeted drug shows promise
Disease control OngoingThis study tests a drug called selumetinib in children and young adults with low grade glioma that has come back or not responded to other treatments. The drug works by blocking certain enzymes that help tumor cells grow. The goal is to find the best dose and see if it can shrink…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
One-Time eye injection could slow blindness in retinitis pigmentosa
Disease control OngoingThis study tests a gene therapy called SPVN06 for retinitis pigmentosa, an inherited eye disease that causes gradual vision loss. The treatment is given as a single injection under the retina. The trial includes 33 adults with advanced disease and will check safety and whether it…
Phase 1/2 • Sponsor: SparingVision • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eye drug takes on leading cause of blindness in the elderly
Disease control OngoingThis study tests a new medicine called BI 771716 for geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. About 202 adults aged 50 and older will receive either the new drug or an existing treatment (pegcetacoplan) as eye injections. T…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New eye injection aims to stop vision loss in dry AMD patients
Disease control OngoingThis study tests whether monthly eye injections of ANX007 can prevent significant vision loss in people with dry age-related macular degeneration (AMD) that has progressed to geographic atrophy. About 659 participants will receive either the drug or a sham injection. The main goa…
Phase 3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New epilepsy drug safety check: 660 patients monitored long-term
Disease control By invitation onlyThis study checks the long-term safety of the drug BHV-7000 in about 660 adults whose focal epilepsy has not been controlled by other treatments. Participants who completed an earlier study will continue taking the drug while doctors watch for side effects and lab changes. The go…
Phase 2 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New eye drug trial aims for safer wet AMD treatment
Disease control OngoingThis early-stage trial tests an experimental drug called OCU-10-C-110, given as an eye injection, in 24 people with wet age-related macular degeneration (nAMD). The main goal is to check safety and tolerability at different doses. Researchers will monitor for side effects over ti…
Phase 1 • Sponsor: Ocugenix Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for wet AMD: two novel drugs enter final testing phase
Disease control OngoingThis Phase 3 study tests two new drugs, tarcocimab tedromer and tabirafusp tedromer, against the standard treatment aflibercept for wet age-related macular degeneration (AMD). The trial involves 675 participants who have not been treated before. The goal is to see if the new drug…
Phase 3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Gene therapy could end frequent eye injections for wet AMD
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment aims to help the eye produce its own medicine to stop leaky blood vessels, potentially replacing the need for repeated eye injecti…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New hope for rare epilepsy: drug shows promise in phase 3 trial
Disease control OngoingThis Phase 3 study tests whether fenfluramine (ZX008) can safely reduce seizures in 87 children and adults with CDKL5 deficiency disorder, a rare genetic condition causing severe epilepsy. Participants receive either the drug or a placebo, followed by an open-label extension wher…
Phase 3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New syringe design tested for common eye disease treatment
Disease control OngoingThis study tests whether a pre-filled syringe is as safe as the traditional vial when giving the medicine bevacizumab for certain eye diseases. About 120 people with wet age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion will receive inject…
Phase 3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Gene therapy for wet AMD: 4-Year safety check begins
Disease control OngoingThis study checks the long-term safety of a gene therapy called EXG102-031 in 12 people with wet age-related macular degeneration (AMD), a condition that can cause severe vision loss. Participants already received the gene therapy in an earlier study and will be monitored for up …
Phase 1 • Sponsor: Exegenesis Bio • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Gene therapy offers hope for rare Blindness-Causing eye disease
Disease control OngoingThis study tests a gene therapy called AGTC-501 in males aged 12 to 50 with X-linked retinitis pigmentosa, a genetic eye disease that causes vision loss. Participants receive one of two doses of the therapy or no treatment, and researchers measure changes in vision under low ligh…
Phase 2/3 • Sponsor: Beacon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Gene therapy for deafness: researchers track long-term safety and hearing gains
Disease control By invitation onlyThis study follows 30 people who previously received a gene therapy (AAVAnc80-hOTOF) for hearing loss caused by otoferlin gene mutations. Researchers will monitor safety over the long term, checking for late side effects, and measure hearing improvements using brain response test…
Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New transplant approach aims to cure blood failure without harming lungs or liver
Disease control OngoingThis study tests a bone marrow transplant method that avoids harsh chemotherapy and radiation for people with dyskeratosis congenita, a genetic disorder causing bone marrow failure. The goal is to fix the blood system without worsening lung or liver disease or raising cancer risk…
Phase 2 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Nasal gene therapy offers new hope for brain injury patients
Disease control By invitation onlyThis study follows 25 people aged 2 to 65 with cerebral palsy or brain damage from lack of oxygen who have already received a new gene therapy given as a nose spray. The therapy delivers 15 genes meant to repair the brain, reduce inflammation, and improve movement and thinking. R…
Sponsor: Healing Hope International • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Painless eye drops could save sight in kids with brain tumors
Disease control OngoingThis study tests a new painless nerve growth factor eye drop (CHF6467) in 36 children and young adults with optic pathway glioma, a brain tumor that often causes vision loss. The goal is to see if the drops can protect or improve vision without the pain side effects of standard n…
Phase 2 • Sponsor: Benedetto Falsini • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can stem cells restore hearing? early trial aims to find out
Disease control By invitation onlyThis early-phase study is testing whether stem cell therapies and experimental drugs can help repair inner ear damage in people with hearing loss or tinnitus. Researchers will monitor 120 adults over time using hearing tests and symptom surveys. The goal is to see if these regene…
Early phase 1 • Sponsor: Truway Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Revolutionary fully implanted hearing device tested in adults
Disease control OngoingThis study tests a fully implanted cochlear implant called Acclaim CI in 56 adults with severe to profound hearing loss. The goal is to see if it helps them hear words better than before and to check for any medical problems. Participants get the implant and are followed for up t…
Sponsor: Envoy Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a cochlear implant beat a hearing aid for kids with one-sided deafness?
Disease control OngoingThis study compares cochlear implants to hearing aids in 80 children aged 4 to 14 with hearing loss in one ear. Researchers measure how well kids understand speech and hear in noise before and after getting an implant. The goal is to see if the implant provides better hearing tha…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New hope for rare eye disease: drug trial targets vision loss
Disease control OngoingThis study tests a drug called tinlarebant in 60 people with Stargardt disease, a genetic condition that causes vision loss. The goal is to see if the drug can slow damage to the retina and preserve eyesight. Participants take the drug or a placebo, and researchers measure change…
Phase 2/3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Balance-Restoring implant trial offers hope for chronic dizziness sufferers
Disease control OngoingThis study is testing a new device called a multichannel vestibular implant for people who have lost most or all of their balance function due to inner ear damage. The implant electrically stimulates the balance nerve to help improve stability and vision during movement. Up to 30…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can smarter hearing aids keep aging brains sharp?
Disease control OngoingThis study tests whether a personalized, data-driven hearing rehabilitation program can improve hearing, thinking, and quality of life in older adults with mild to moderate hearing loss. Two hundred first-time hearing aid users will be randomly assigned to either the new personal…
Sponsor: Kuopio University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
One-Time gene injection aims to restore sight in rare eye disease
Disease control OngoingThis phase 3 trial tests a gene therapy called LX101 in 30 people with inherited retinal dystrophy caused by RPE65 mutations. Participants receive a single injection of LX101 into the eye, while a control group gets no treatment. The study measures changes in functional vision an…
Phase 3 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Experimental gene therapy aims to restore sight in rare eye disease
Disease control OngoingThis early study tests a gene therapy called LX101 in 9 people with a rare inherited eye disease caused by RPE65 gene mutations. The therapy delivers a working copy of the gene into the retina via a single injection. The main goals are to check safety and see if it can improve vi…
Phase 1 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
One-and-Done gene shot could spare wet AMD patients from monthly eye needles
Disease control OngoingThis phase 2 trial tests a gene therapy called LX102 for wet age-related macular degeneration (nAMD), a leading cause of vision loss. The therapy is injected under the retina and aims to produce a protein that blocks abnormal blood vessel growth, potentially reducing the need for…
Phase 2 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Glasses that 'Talk' to Gene-Edited eyes: a new hope for blindness?
Disease control OngoingThis early-stage trial tests a combination treatment for retinitis pigmentosa, a genetic disease that causes blindness. Ten adults receive a single injection of GS030 gene therapy into one eye, then use special glasses that send light signals to the treated retina. The main goal …
Phase 1/2 • Sponsor: GenSight Biologics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy shot could end monthly eye injections for wet AMD
Disease control OngoingThis study tests a gene therapy called RGX-314 for wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment is given as one or two injections into the eye and aims to produce proteins that block abnormal blood vessel growth, potentially replacing …
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gene therapy injection aims to restore sight in rare eye diseases
Disease control OngoingThis early-phase trial tests a single injection of a gene therapy called RTx-015 in 10 adults with retinitis pigmentosa or choroideremia, two inherited conditions that cause vision loss. The therapy delivers a gene that makes retinal cells produce a light-sensitive protein, poten…
Phase 1 • Sponsor: Ray Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Sound waves instead of surgery: new device tested for vein disease
Disease control OngoingThis study tests whether a device called Sonablate can safely use high-intensity focused ultrasound (HIFU) to treat vein problems like varicose veins, leg ulcers, and certain birth defects. About 30 adults with these conditions will receive the treatment, which does not involve c…
Sponsor: Sonablate • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a stronger eylea dose cut eye injections in half?
Disease control OngoingThis study tests whether switching wet AMD patients who don't respond well to the standard 2mg dose of aflibercept (Eylea) to a higher 8mg dose can extend the time between injections while keeping vision stable. Fifty adults who have already had at least four 2mg injections will …
Sponsor: Vienna Institute for Research in Ocular Surgery • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
One-Shot gene therapy could replace monthly eye injections for wet AMD
Disease control OngoingThis early-stage trial tests a single injection of ABI-110 gene therapy into the eye for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if it is safe and can reduce the need for frequent anti-VEGF injections by helping t…
Phase 1/2 • Sponsor: Avirmax Biopharma Inc • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gene therapy for wet AMD: could this mean fewer eye injections?
Disease control OngoingThis study follows 23 people with wet age-related macular degeneration who received a single dose of ADVM-022 gene therapy in an earlier trial. Researchers are checking how safe the treatment is over time and whether it continues to control the disease, potentially reducing the n…
Sponsor: Adverum Biotechnologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Stem cells injected into eyes: a new hope for blindness?
Disease control OngoingThis early-stage trial is testing whether it is safe to inject a person's own bone marrow stem cells into their eye to treat vision loss from conditions like macular degeneration and diabetic retinopathy. Fifteen adults with severe vision loss will receive the injection and be mo…
Phase 1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a magnetic device and daily vitamins speed up wrist fracture recovery?
Disease control OngoingThis study tests whether adding a daily supplement (vitamins D, K, C, magnesium, zinc, copper) to pulsed electromagnetic field therapy helps women aged 45-55 heal faster from a wrist fracture. Sixty women will either use the device alone or the device plus supplement for 30 days.…
Sponsor: University of Palermo • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gene therapy for macular degeneration: is it safe years later?
Disease control OngoingThis study follows 18 people who already received RetinoStat, a gene therapy for wet age-related macular degeneration, to see if it remains safe over time. Researchers track side effects and vision changes. The goal is to understand long-term risks, not to test if the treatment w…
Phase 1 • Sponsor: Oxford BioMedica • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Bionic balance: implant aims to steady patients with inner ear disorder
Disease control OngoingThis trial is testing a combined cochlear and vestibular implant (CVI) in 13 people who have lost both hearing and balance function due to bilateral vestibulopathy. The implant stimulates the nerves for hearing and balance to see if it can improve stability, vision during movemen…
Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
One shot to restore hearing? new drug takes on steroids
Disease control OngoingThis study tests a single injection of a new drug called AC102 into the ear, comparing it to standard steroid pills for sudden hearing loss. About 210 adults with hearing loss in one ear will take part. The goal is to see if the injection improves hearing better than steroids, wi…
Phase 2 • Sponsor: AudioCure Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
One shot gene therapy could end monthly eye injections for wet AMD
Disease control OngoingThis early-stage trial tests a gene therapy called KH658 for people with wet age-related macular degeneration (AMD). The treatment aims to deliver a protein that blocks abnormal blood vessel growth, potentially reducing the need for frequent eye injections. Nine participants aged…
Phase 1 • Sponsor: Chengdu Origen Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a pill save your sight? new trial targets blinding eye disease
Disease control OngoingThis Phase 3 trial tests whether a daily pill called tinlarebant can slow the growth of geographic atrophy, an advanced form of age-related macular degeneration that causes blind spots. About 429 adults with the condition will receive either the drug or a placebo for up to 2 year…
Phase 3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a single gene shot replace monthly eye injections for wet AMD?
Disease control OngoingThis early-stage trial tests a gene therapy called KH631 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The treatment aims to deliver a protein that blocks harmful blood vessel growth, potentially reducing the need for frequent eye inj…
Phase 1 • Sponsor: Chengdu Origen Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New injection could shrink skin cancer before surgery
Disease control OngoingThis study tests an experimental drug called RP1 that is injected directly into skin cancer tumors. The goal is to see if it can shrink or eliminate the cancer before surgery. Up to 12 adults with a type of skin cancer called cutaneous squamous cell carcinoma will take part. The …
Phase 1/2 • Sponsor: Sherrif Ibrahim • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Gene therapy injection aims to halt blindness from rare eye disorder
Disease control OngoingThis Phase 3 trial tests a gene therapy called VGR-R01 for Bietti crystalline dystrophy, a rare inherited condition that leads to progressive vision loss. The study will enroll 45 adults who receive either the gene therapy injection under the retina or a control treatment. Resear…
Phase 3 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Gene therapy trial aims to halt blindness from rare crystal disease
Disease control OngoingThis early-stage trial tests a gene therapy called VGR-R01 for Bietti Crystalline Dystrophy, a rare inherited eye disease that leads to progressive vision loss. The study involves 12 adults who receive the therapy via injection into the eye. The main goal is to check safety and t…
Phase 1 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New device may save hearing options after brain tumor removal
Disease control CancelledThis study was designed to see if a small device placed in the inner ear during acoustic neuroma surgery can keep the cochlea from filling with scar tissue. If successful, patients who lose hearing from the surgery could still get a cochlear implant later. The study was withdrawn…
Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could wet AMD patients get fewer eye shots? new study tests early treatment breaks
Disease control OngoingThis study compares two drugs, aflibercept and brolucizumab, for wet age-related macular degeneration (AMD). Instead of the usual three monthly loading doses, it tests starting with longer intervals between injections right away. The goal is to see if this approach works just as …
Sponsor: Berner Augenklinik • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Avastin vs eylea: which eye drug needs fewer shots?
Disease control OngoingThis study compares two drugs, Avastin and Eylea, given as eye injections for wet age-related macular degeneration (AMD). The main goal is to see which drug requires fewer injections over two years while still controlling the disease. Researchers will also check vision, eye thick…
Phase 2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eye drops could replace needles for wet AMD? new trial underway
Disease control OngoingThis study tests whether KHK4951 eye drops can safely improve vision in people with wet age-related macular degeneration (nAMD), a leading cause of vision loss. About 180 participants will use the drops or a placebo for several months. The goal is to see if the drops reduce fluid…
Phase 2 • Sponsor: Kyowa Kirin Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Custom drug targets rare blindness in One-Patient trial
Disease control OngoingThis study tests a custom-made drug called an antisense oligonucleotide, designed specifically for one person with retinal dystrophy caused by a PRPH2 gene mutation. The drug aims to correct the genetic error and potentially slow vision loss. The trial involves only one participa…
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
New hope for epilepsy: Real-World data on Cenobamate's impact
Disease control OngoingThis study looks at how well the drug cenobamate works for adults with focal seizures that don't improve with at least two other epilepsy medicines. Researchers are collecting data from Italian clinics and a compassionate use program to measure seizure reduction and side effects.…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated Jun 26, 2026 15:21 UTC
-
Eye implant for diabetes? trial pulled before it began
Disease control CancelledThis study aimed to transplant insulin-producing cells into the front chamber of the eye for people with type 1 diabetes and poor vision. The goal was to see if the procedure was safe for the eye. However, the trial was withdrawn before enrolling any participants, so no results a…
Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 26, 2026 13:07 UTC
-
Rotation chairs face off: can a newer device match the gold standard for vertigo diagnosis?
Diagnosis By invitation onlyThis study tests whether two mechanical rotation chairs—the TRV and the newer Rotundum—are equally accurate at diagnosing benign paroxysmal positional vertigo (BPPV), a common cause of brief dizzy spells triggered by head movements. About 200 adults with typical BPPV symptoms wil…
Sponsor: Aalborg University Hospital • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
New ultrasound otoscope aims to spot ear infections with greater accuracy
Diagnosis OngoingThis study tests an advanced ultrasound otoscope, a device that uses sound waves to look inside the ear and detect fluid behind the eardrum. Researchers will compare its readings to the surgeon's findings during ear tube surgery in 300 children up to 12 years old. The goal is to …
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Could a tiny jolt to the head diagnose balance problems?
Diagnosis By invitation onlyThis early study will test whether weak electrical currents applied to the head can help diagnose balance disorders like vestibular schwannoma and vestibular neuritis. Researchers will measure how 30 people with these conditions sway or move in response to the stimulation. The go…
Sponsor: Aalto University • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
AI eye check could save your sight: new trial tests smart screening for diabetes patients
Diagnosis By invitation onlyThis study tests whether using artificial intelligence (AI) to screen for diabetic eye disease during regular primary care visits helps more people get timely eye exams and follow-up care. About 1,700 adults with diabetes who haven't had an eye exam in the past year will take par…
Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
New app could spot eye disease from your couch
Diagnosis By invitation onlyThis study is testing a smartphone app called NEDS EyeCTester to see if it can help detect active eye disease early in people with conditions like optic nerve or macular disease. About 100 participants will use the app at home, and researchers will compare the results to standard…
Sponsor: Neuro-Eye Diagnostic Systems, LLC • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
AI eye test could spot vision loss faster and cheaper
Diagnosis OngoingThis study tests whether an AI-assisted screening tool can detect visual impairment more accurately and efficiently than traditional methods in community settings. About 400 adults aged 50 and older will undergo vision screening and provide feedback. The goal is to see if the AI …
Sponsor: Singapore Eye Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Revolutionary eye camera could catch blindness early
Diagnosis OngoingThis study tests a new, ultra-high-resolution eye scanner that combines two imaging techniques to see the retina in 3D. Researchers will scan 10 healthy adults and 40 people with early or intermediate age-related macular degeneration (AMD). The goal is to improve early detection …
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Eye-Tracking tech could spot macular degeneration faster
Diagnosis OngoingThis study tests a device called AVIGA that tracks eye movements to detect vision problems in people with wet age-related macular degeneration (AMD). Researchers will compare the device's results with standard eye exams to see if it can reliably spot disease activity. The goal is…
Sponsor: Tan Tock Seng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Could epidurals shield new mothers from postnatal depression?
Prevention OngoingThis trial asks whether the type of pain relief a woman receives during labor can influence her risk of developing postnatal depression. About 10-15% of new mothers experience postnatal depression, and this study compares epidural analgesia with non-epidural options like laughing…
Phase 2/3 • Sponsor: KK Women's and Children's Hospital • Aim: Prevention
Last updated Aug 08, 2026 00:03 UTC
-
Can a 3-Minute video beat a pamphlet at saving hearing?
Prevention By invitation onlyThis trial tests whether a short video or a paper handout is better at teaching hospital workers how to insert earplugs correctly. About 64 staff who work in noisy areas will be randomly assigned to one training method, then tested right after and again one week later. The goal i…
Sponsor: Sirinthorn Chanaveroj • Aim: Prevention
Last updated Jul 30, 2026 00:00 UTC
-
Hearing loss prevention pill put to the test — but study never started
Prevention CancelledThis study aimed to test whether an oral drug called SPI-1005 (ebselen) could prevent temporary hearing loss caused by loud noise. Researchers planned to enroll adults aged 18-50 with a history of noise exposure and give them the drug or a placebo for 7 days, then measure hearing…
Phase 2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New pill aims to stop chemo from stealing hearing
Prevention CancelledThis study was designed to test whether an oral drug called SPI-1005 could prevent hearing loss and ringing in the ears caused by platinum-based chemotherapy. It was planned for adults with advanced lung or head and neck cancer. The study was withdrawn before enrolling any partic…
Phase 2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Hearing loss shield tested in kids with liver cancer
Prevention PausedThis study tests whether sodium thiosulfate can prevent hearing loss in children and young adults (ages 1 month to 39 years) who are receiving cisplatin chemotherapy for relapsed or hard-to-treat liver tumors and other embryonal cancers. Some participants also get vorinostat. The…
Early phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
Turmeric compound tested against the ringing in millions of ears
Symptom relief CancelledResearchers are testing whether a highly absorbable form of curcumin, the main compound in turmeric, can reduce the bothersome ringing or buzzing of subjective tinnitus. The study enrolls adults whose tinnitus comes from sensorineural hearing loss, confirmed by a routine hearing …
Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Hyaluronic acid gel vs standard paste: which calms infected root canals better?
Symptom relief OngoingResearchers compare two medicines placed inside root canals during a two-visit root canal treatment for infected mandibular molars. One medicine is Hyalone, a hyaluronic acid gel, and the other is calcium hydroxide, a standard disinfectant paste. The trial enrolls 24 adults with …
Early phase 1 • Sponsor: Future University in Egypt • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
A brief video program aims to ease the emotional toll of vision loss
Symptom relief By invitation onlyThis study tests whether a short audiovisual educational program can help people with vision loss better understand and cope with common emotional challenges like grief and isolation. Participants answer questions, watch the program, and then answer more questions. The goal is to…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can an epidural pump beat IV painkillers after liver surgery?
Symptom relief OngoingThis trial compares two ways to control pain after open liver surgery: an epidural pump that delivers pain medicine near the spine, versus a standard IV pump. About 230 adults having elective open liver resection will be randomly assigned to one method. The goal is to see which a…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Could a liver drug help people see color? tiny trial launched
Symptom relief PausedThis early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…
Early phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Magnetic pulses to the brain: a new way to sharpen failing eyesight?
Symptom relief OngoingResearchers are testing whether transcranial magnetic stimulation (TMS), a non-invasive procedure that delivers magnetic pulses to the visual cortex, can improve eyesight in people with visual impairment. The trial enrolls 300 adults who have had cataract surgery or have a clear …
Sponsor: Evidence Based Cataract Study Group • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New hope for teens: could a simple infusion cut opioid use after spine surgery?
Symptom relief By invitation onlyThis study looks at whether adding a low-dose dexmedetomidine infusion to standard pain management can lower the amount of narcotics needed and reduce side effects like nausea and itching in teenagers having posterior spinal fusion for scoliosis. About 160 adolescents with idiopa…
Phase 2 • Sponsor: Nichole Doyle • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a daily pill quiet the spinning of vertigo?
Symptom relief CancelledResearchers are testing an experimental oral tablet called APSLXR in people with Meniere's disease or vertigo of vestibular origin. The main goal is to check whether the drug is safe when taken once a day for 60 days. A small group will also have blood tests to see how the body p…
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Terpenes: the next frontier in pain relief?
Symptom relief OngoingThis study looks at whether terpenes—natural compounds found in plants—can reduce pain when taken alone or with THC. Researchers will test 45 adults who use cannabis regularly to measure pain relief and any feelings of being high or drug liking. The goal is to find safer ways to …
Phase 1 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Reformer pilates may steady the steps of children with visual impairment
Symptom relief OngoingThis trial tests whether a 6-week Reformer Pilates program can improve balance, walking patterns, and muscle strength in children and adolescents with visual impairment. Participants aged 10 to 17 are randomly assigned to either the exercise group or a control group that continue…
Sponsor: Marmara University • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Writing as medicine: can words soothe chronic pain?
Symptom relief CancelledThis study looks at whether a guided therapeutic writing program can help adult women with chronic pain and co-occurring mental health conditions. Participants will complete writing exercises focused on emotional processing and meaning-making over four weeks, then share their exp…
Sponsor: Toni Salikka • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Spinal zaps and exercise may boost walking after injury
Symptom relief OngoingThis study tests whether combining motor skill training with a non-invasive spinal stimulation can improve walking, balance, and strength while reducing muscle spasticity in people with incomplete spinal cord injury. Twenty-eight participants will do a series of standing exercise…
Sponsor: Shepherd Center, Atlanta GA • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Shocking the nerve: can a stimulator make pain blocks better?
Symptom relief By invitation onlyThis study tests whether adding a nerve stimulator to standard ultrasound guidance improves the quality of nerve blocks for upper limb surgery. 82 adults having elective arm surgery will be randomly assigned to receive the block with or without the stimulator active. Researchers …
Sponsor: Stanford University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New pain block cocktail may cut opioid use after breast surgery
Symptom relief OngoingThis trial compares two ultrasound-guided nerve blocks—serratus-intercostal and erector spinae—both using a mix of bupivacaine and dexmedetomidine to control pain after mastectomy. The goal is to see which block reduces the need for morphine and improves pain scores. Seventy wome…
Sponsor: Zagazig University • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New study aims to ease pain after gynecologic surgery
Symptom relief OngoingThis study tests whether a nerve block given before surgery (TAP block) works as well as numbing medicine injected into the wound by the surgeon for controlling pain after gynecologic cancer surgery. About 80 women having surgery through a vertical belly cut will take part. The g…
Phase 4 • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Gentle pressure, less pain? acupressure may soothe kids during wire removal
Symptom relief OngoingThis trial tests whether acupressure, a technique that applies gentle pressure to specific body points, can reduce pain, fear, and anxiety in children aged 6-12 during removal of K-wires (thin metal pins used to heal elbow fractures). Children will be randomly assigned to receive…
Sponsor: Cukurova University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
CBD as a calming agent for Scan-Related anxiety in advanced breast cancer?
Symptom relief OngoingThis study tests whether a single oral dose of cannabidiol (CBD) can reduce the anxiety people with advanced breast cancer feel before undergoing CT or PET scans. Participants are randomly assigned to receive either CBD or a placebo, and their anxiety levels are measured before a…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Can surgery pain be managed without opioids?
Symptom relief OngoingThis trial asks whether an opioid-free anesthesia method can control acute pain after laparoscopic colorectal surgery as well as or better than standard opioid-based anesthesia. Adults aged 18 to 90 scheduled for this surgery will be randomly assigned to receive either a combinat…
Phase 1/2 • Sponsor: Hospital Universitario La Fe • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Heart surgery pain relief: which methadone dose works best?
Symptom relief CancelledThis study looks at three different ways to give methadone during heart surgery to find the best dose for controlling pain afterward. About 69 adults having planned heart surgery will take part. Researchers will measure methadone levels in the blood and ask about pain to see whic…
Phase 4 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New electric therapy aims to treat depression without memory loss
Symptom relief OngoingThis small study tests a new treatment called TEST for people with depression that hasn't improved with standard treatments. TEST uses a lower electric current than standard electroconvulsive therapy (ECT), aiming to avoid memory and thinking problems. Eight adults aged 25-64 wil…
Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Can an online program replace clinic visits for hearing aid users?
Symptom relief OngoingThis study looks at how different types of follow-up support affect new hearing aid users. Participants can choose an online program, a clinic visit, or no follow-up. The goal is to see if the online option helps reduce the emotional and social impact of hearing loss as much as a…
Sponsor: Region Skane • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could a simple playlist be the new painkiller? Music's power over surgery anxiety put to the test
Symptom relief OngoingThis trial tests whether listening to music for 30 minutes before and after surgery can reduce pain, anxiety, and the need for painkillers in women undergoing gynecologic surgery. Participants will choose from several music genres and report their pain, anxiety, and satisfaction …
Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Could a VR headset replace pills for surgery anxiety?
Symptom relief OngoingThis trial tests whether using virtual reality (VR) relaxation before and after gynecologic surgery can reduce anxiety and pain. About 220 women undergoing day or inpatient gynecologic procedures will either use a VR headset with calming scenes or receive standard care. Researche…
Sponsor: KK Women's and Children's Hospital • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Home exercises may steady the steps of seniors with dizziness
Symptom relief OngoingThis pilot trial tests whether a home-based exercise program, paired with a self-guided education booklet, can help adults aged 60 and older who have benign paroxysmal positional vertigo (BPPV) with or without vestibular hypofunction. Participants are randomly assigned to either …
Sponsor: Muhammad Hizami bin Mustafa • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
Can we skip opioids in Weight-Loss surgery? new study tests safer pain control
Symptom relief OngoingThis study looks at two ways to manage pain during weight-loss surgery (sleeve gastrectomy) in 70 adults. One group gets standard opioid painkillers, the other gets a mix of non-opioid drugs. The goal is to see if the opioid-free approach can reduce opioid use and still control p…
Sponsor: G.Gennimatas General Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
CT-Guided tuning: a new way to Fine-Tune cochlear implants?
Symptom relief By invitation onlyThis trial tests a new method called image-guided cochlear implant programming (IGCIP) that uses CT scans to map the exact position of electrodes inside the ear. By deactivating poorly placed electrodes, the approach aims to customize implant settings for better hearing. Adults a…
Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Can a Video-Call program help people with HIV tackle pain and drinking?
Symptom relief OngoingThis study tests a telehealth program called MCBMAP that combines counseling and skills training to help people with HIV reduce chronic pain and unhealthy drinking. The program is delivered entirely through video calls and online materials, making it easier for participants to jo…
Sponsor: Boston University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Eye exercises may help relieve 'Text Neck' pain
Symptom relief By invitation onlyThis study tests whether adding simple eyeball exercises to standard neck physiotherapy can better relieve pain and improve posture in people with text neck syndrome—a condition caused by prolonged device use. Participants will be randomly assigned to receive either physiotherapy…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Acupuncture needles take on chemo nerve pain in major trial
Symptom relief OngoingThis study tests if acupuncture can reduce nerve pain caused by chemotherapy in cancer survivors. About 255 people who finished chemo at least three months ago will receive either real or sham acupuncture. The goal is to see if this drug-free approach can ease pain and improve da…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Brain wave test may reveal tinnitus relief
Symptom relief OngoingThis study looks at whether changes in brain waves can objectively measure tinnitus improvement after using a non-invasive device. The device delivers sound through headphones and mild electrical pulses to the tongue. Twenty-four adults with chronic tinnitus will use the device d…
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Vibrating platform may improve balance and thinking in Parkinson's
Symptom relief OngoingThis study investigates whether whole-body vibration (WBV) therapy, added to standard exercise, can improve balance, walking, thinking, and the ability to do two things at once in people with Parkinson's disease. Participants will be randomly assigned to receive either low-freque…
Sponsor: Izmir Bakircay University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could virtual reality help soothe dizziness better than standard therapy?
Symptom relief OngoingThis study tests whether virtual reality-assisted vestibular rehabilitation can reduce dizziness and improve balance and walking more than conventional vestibular rehabilitation in people with benign paroxysmal positional vertigo (BPPV). Participants, aged 18 to 40 with residual …
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New prism device may help one-eyed pedestrians avoid collisions
Symptom relief CancelledThis study tested a prism device designed to expand the field of view for people who have lost vision in one eye. The goal was to see if the prism helps them detect pedestrians approaching from their blind side during a simulated walking task. Only one person participated before …
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Ultrasound-Guided injections may offer superior pain relief for common arm conditions
Symptom relief OngoingThis study compares three treatments for shoulder impingement and carpal tunnel syndrome: ultrasound-guided corticosteroid injections, standard injections guided by touch, and oral pain medication. Researchers want to see which approach provides the best long-term pain relief, im…
Phase 4 • Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Can deep breathing and acupuncture ease stubborn neck pain?
Symptom relief By invitation onlyThis trial investigates whether adding diaphragmatic breathing and electroacupuncture to standard physiotherapy can better relieve chronic neck pain, improve posture, and reduce disability. Seventy-two adults with at least three months of neck pain and poor breathing patterns wil…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
New injection hopes to heal scarred vocal cords and restore voice
Symptom relief OngoingThis study tests an injection called KP-100LI for people with vocal fold scars that cause voice problems. About 62 adults will receive either the study drug or a placebo to see if it improves voice function over 24 weeks. The goal is to confirm the treatment is safe and effective…
Phase 3 • Sponsor: Kringle Pharma, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New program helps epilepsy patients better manage rescue meds
Symptom relief OngoingThis study aims to help people with epilepsy who have repeated seizures learn how to use rescue medication more effectively. In the first phase, patients, caregivers, and doctors will help design an educational program. In the second phase, about 35 adults will try the program fo…
Phase 4 • Sponsor: University Hospitals Cleveland Medical Center • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Bedtime stories for autism? Single-Child trial shows early gains
Symptom relief OngoingThis study tests whether listening to special audio fairy tales before sleep can improve speech, motor skills, and independence in a child with autism and central auditory processing disorder. The child stays at home with their mother, avoiding clinic stress. Early results from t…
Sponsor: Natalia Poluektova • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New pain block could cut opioid use after back surgery
Symptom relief OngoingThis study tests whether a targeted nerve block (retrolaminar block) provides better pain relief after lumbar discectomy than the standard method of injecting pain medicine into the surgical wound. 130 adults having elective single-level herniated disc surgery will be randomly as…
Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
Flickering glasses aim to sharpen Athletes' vision and batting skills
Symptom relief OngoingThis pilot study tests whether stroboscopic vision training glasses can enhance visual and athletic performance in high school softball players. The glasses flicker between clear and opaque, briefly removing visual information to train the connection between eyes, brain, and body…
Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Could a tiny dose of naltrexone calm CRPS pain? new study aims to find out.
Symptom relief By invitation onlyThis study tests whether a very low dose of naltrexone, a drug usually used for addiction, can reduce pain and other symptoms in people with Complex Regional Pain Syndrome (CRPS). Forty adults with CRPS will receive either the drug or a placebo for six months. The main goal is to…
Phase 4 • Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Talking it out: therapy group aims to ease parents' stress in rare blindness condition
Symptom relief OngoingThis study tests whether group psychotherapy can help parents of children with Leber congenital amaurosis (LCA) feel better emotionally and handle stress. Forty parents will take part, with half joining therapy groups and the other half serving as a comparison. Researchers will m…
Sponsor: Instituto de Genética Ocular • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
VR goggles could replace sedation for vein surgery patients
Symptom relief By invitation onlyThis study tests whether wearing a virtual reality headset during laser treatment for varicose veins can lower anxiety and pain. About 100 adults will use VR during the procedure, and researchers will measure their heart rate, blood pressure, and comfort levels. The goal is to se…
Sponsor: Bydgoszcz University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New speech therapy approach tested for kids with apraxia
Symptom relief OngoingThis study tests a speech therapy method called Rapid Syllable Transition (ReST) in children aged 5 to 8 with childhood apraxia of speech, a condition that makes it hard to say sounds correctly. The goal is to see if the therapy is practical and helps improve speech clarity and m…
Sponsor: Aline Mara de Oliveira • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New dashboard aims to cut pain for tiniest patients
Symptom relief OngoingThis study tests a computer dashboard that helps doctors and nurses in the Neonatal Intensive Care Unit (NICU) manage pain in newborn babies. The dashboard shows real-time data to flag when a baby may be in discomfort. Researchers will compare pain levels in 1,250 babies before a…
Sponsor: Erasmus Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New nerve block could cut opioid use after hip surgery
Symptom relief By invitation onlyThis study tests whether a quadratus lumborum (QL) nerve block can reduce pain and the need for opioid painkillers after hip replacement surgery. 80 adults having a first-time hip replacement will receive the block, and their pain scores and opioid use will be tracked for 48 hour…
Early phase 1 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New shot could ease pain after knee surgery for days
Symptom relief PausedThis study tests a single injection of F14, a long-acting form of the painkiller celecoxib, in 100 people undergoing total knee replacement. The goal is to see if it safely controls pain as part of a standard pain management plan. Participants receive the injection during surgery…
Phase 2/3 • Sponsor: Arthritis Innovation Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Could cochlear implants help more people hear? new study expands eligibility.
Symptom relief OngoingThis study looks at whether cochlear implants are safe and effective for adults with severe hearing loss in both ears who currently don't meet standard implant criteria. Fifty participants will receive an implant and be followed for 6 months to measure improvements in word recogn…
Sponsor: Cochlear • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New speech therapy shows promise for kids with apraxia
Symptom relief OngoingThis study tests a therapy called Dynamic Temporal and Tactile Cuing (DTTC) to help children with childhood apraxia of speech, a disorder that makes it hard to plan and coordinate speech movements. The trial involves 72 children and measures how well they can say treated and new …
Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Parent training boosts speech therapy for kids with apraxia
Symptom relief OngoingThis study looks at whether training parents to help with speech therapy at home improves outcomes for children with childhood apraxia of speech (CAS). Forty children aged 2 to 7 will receive standard speech therapy twice a week for 8 weeks. Some parents will get direct coaching …
Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Nerve block may cut opioid use in Kids' ear surgery
Symptom relief PausedThis study tests whether adding a superficial cervical plexus block to standard care reduces opioid use and pain in children aged 3 months to 18 years undergoing ear surgery (cochlear implant or tympanomastoidectomy). Half the children get the block plus standard care, the other …
Phase 4 • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Brain training vs. pain pills: new study aimed to ease Post-Surgery shoulder pain
Symptom relief CancelledThis study planned to compare two approaches for managing pain after shoulder surgery: neurofeedback training (a technique that teaches you to control your brain activity) and a standard pain management program. The goal was to see which method better reduces pain, improves shoul…
Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New DMSO combo therapy targets ringing ears in Long-COVID patients
Symptom relief By invitation onlyThis pilot study tests a compounded DMSO-based ear drops and cream for adults with bothersome tinnitus linked to long-COVID or post-COVID-19 vaccine injury. Twenty participants who have not improved with at least two prior treatments will use the ear drops every 4 days and apply …
Phase 2 • Sponsor: Leading Edge Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Pain relief study for kids pulled before it started
Symptom relief CancelledThis study was designed to test a new pain medicine called HTX-011 in children and teens (ages 3 to 17) after hernia surgery. The goal was to see how well it controls pain and how safe it is. However, the study was withdrawn before any participants were enrolled, so no results ar…
Phase 2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New combo therapy aims to stop the spins in common inner ear disorder
Symptom relief OngoingThis study tests whether adding balance training, education, and vestibular rehab to the standard Epley maneuver helps people with benign paroxysmal positional vertigo (BPPV) more than the maneuver alone. Forty-six adults with BPPV will receive either the combined approach or sta…
Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Frozen nerves to fight surgery pain? trial pulled before it began
Symptom relief CancelledThis study aimed to see if freezing certain nerves during minimally invasive heart surgery could lower pain afterward. It planned to enroll adults having mitral valve or atrial septal defect repair. However, the trial was withdrawn before any participants were enrolled, so no dat…
Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New care plan aims to cut opioid use after accidents
Symptom relief OngoingThis trial tests whether a Pain and Coordination Plan (PAC-plan) can reduce opioid use and improve quality of life in adults who have had surgery after an accidental injury. Participants receive the plan at hospital discharge, which includes an opioid management plan, a follow-up…
Sponsor: University of Oslo • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Talking your way to better hearing: study tests counseling for new hearing aid users
Symptom relief By invitation onlyThis study tests whether motivational interviewing, a counseling style that encourages behavior change, can help new hearing aid users wear their devices more often and feel better about their hearing. Researchers will enroll 180 adults who are new to hearing aids and compare tho…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New combo aims to ease shoulder surgery pain
Symptom relief By invitation onlyThis study looks at whether adding dexamethasone or dexmedetomidine to the usual numbing medicine (bupivacaine) can improve pain relief after shoulder arthroscopy. About 100 adults having elective shoulder surgery will take part. The goal is to reduce pain and help recovery.
Phase 2/3 • Sponsor: New Valley University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a gentle brain zap improve speech in progressive language disorders?
Symptom relief OngoingThis study tests whether a gentle, low-level electric current applied to specific brain areas can improve speech and language difficulties in people with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS). The treatment is called high-definition transcrani…
Sponsor: The University of Texas at Dallas • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
ER pain study pulled before it even started
Symptom relief CancelledThis study aimed to compare an oral morphine tablet to a nasal spray painkiller (sufentanil) for treating severe acute pain in emergency departments. It planned to enroll adults with severe pain, measuring pain levels 30 minutes after treatment. However, the study was withdrawn b…
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can VR help MS patients with dizziness? trial planned but withdrawn
Symptom relief CancelledThis pilot study aimed to test whether immersive virtual reality (VR) exercises could help people with multiple sclerosis who experience dizziness, balance issues, and fatigue. Participants would have been randomly assigned to either VR-based vestibular rehab or conventional exer…
Sponsor: Maria Jesus Casuso-Holgado • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple ear device help stroke survivors find their words?
Symptom relief By invitation onlyThis study tests whether a non-invasive device that gently stimulates the vagus nerve through the ear can improve speech recovery in people with aphasia after stroke or brain injury. Twelve adults with apraxia of speech will receive either active or sham stimulation during 16 wee…
Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Throat nerve block may speed recovery after sleep apnea surgery
Symptom relief OngoingThis study tests whether a numbing injection near the glossopharyngeal nerve, combined with topical anesthesia, can help people recover faster after surgery for obstructive sleep apnea. The trial involves 80 adults with moderate to severe sleep apnea who are scheduled for palatop…
Sponsor: Zagazig University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Tinnitus relief from your couch: online counseling tested
Symptom relief By invitation onlyThis study tests whether online group counseling sessions can help people with chronic tinnitus. Researchers want to see if e-health works as well as traditional in-person sessions. 150 adults with subjective, chronic tinnitus will participate. The main goal is to measure changes…
Sponsor: University Hospital, Antwerp • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Brain training for dizziness: study pulled before it began
Symptom relief CancelledThis study aimed to see if a computer-based cognitive training program could improve spatial thinking, balance, and quality of life in people with long-term dizziness from inner ear problems. The training was meant to be used alongside standard physical therapy. However, the stud…
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Sound-Guided gaze: new device aims to sharpen eye imaging for the visually impaired
Symptom relief By invitation onlyThis study tests a device that uses real-time sound feedback to help people with vision loss fix their gaze on a target. Participants hear sounds that guide their eyes back to center when they drift. The goal is to improve the quality of eye imaging by reducing blur from eye move…
Sponsor: University Medical Center Goettingen • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New app aims to fight hospital delirium in seniors
Symptom relief PausedThis study tests a mobile app called iPREPARED that helps patients and their caregivers prepare for a hospital stay. The app provides videos and tips to prevent or reduce delirium, a sudden confused state common in older adults. Researchers want to see if the app is easy to use a…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New gel could make eye injections Pain-Free
Symptom relief By invitation onlyThis study compares a new numbing gel (chloroprocaine HCl 3%) to standard eye drops plus a shot for pain relief during eye injections. About 236 adults with conditions like diabetic macular edema or age-related macular degeneration will take part. The goal is to see if the gel wo…
Phase 4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Telehealth therapy aims to cut opioid use for back pain sufferers
Symptom relief OngoingThis study tests two telehealth-based treatments—brief pain education and 10 weeks of physical therapy—to help 500 adults with chronic low back pain. The goal is to improve pain management and reduce opioid use in community health centers. Participants receive sessions via phone …
Phase 3 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Ear seeds ease pain during uterine exam?
Symptom relief OngoingThis study looks at whether a special ear therapy (Bagua auriculotherapy) can help reduce pain and anxiety in women having a hysteroscopy, a procedure to look inside the uterus. About 132 women aged 20 to 45 will receive this ear treatment along with standard care. The goal is to…
Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New numbing shot could cut opioid use after nose jobs
Symptom relief By invitation onlyThis study tests whether a long-acting numbing medication (liposomal bupivacaine) can better control pain after septorhinoplasty (nose surgery) compared to standard numbing drugs or a placebo. About 72 adults having nose surgery will receive one of three treatments at the end of …
Phase 3 • Sponsor: Jessyka Lighthall • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Brain training may boost hearing and thinking in older cochlear implant users
Symptom relief By invitation onlyThis study tests whether an 8-week auditory-cognitive training program can improve speech recognition and cognitive function in older adults (60+) who have had a cochlear implant for 3 months to 3 years. Participants will do computer-based listening and thinking exercises at home…
Sponsor: Gallaudet University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New study tests better pain control after abdominal surgery
Symptom relief OngoingThis study compares three ways to manage pain after lower abdominal surgery: a spinal injection of morphine, a nerve block in the abdominal wall, or standard painkillers. Sixty-six adults having surgery through a midline incision will be randomly assigned to one of these groups. …
Sponsor: Marmara University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Which pain block is best after breast surgery? new study aims to find out
Symptom relief OngoingThis study compares two types of nerve blocks (superficial vs. deep) for pain relief after breast surgery. 58 women will receive one of the two blocks, and researchers will measure how much pain medication they need in the first 24 hours. The goal is to find which block provides …
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Cochlear implant users may hear better in crowds with new sound settings
Symptom relief By invitation onlyThis study tests different automatic sound management features on MED-EL cochlear implants to see which helps adults hear speech best in background noise. About 20 experienced cochlear implant users will listen to sentences in noise and report what they hear. The goal is to find …
Sponsor: Med-El Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could a ketamine injection during jaw surgery cut Post-Op pain?
Symptom relief OngoingThis study tests whether injecting a low dose of ketamine directly into the jaw during surgery can reduce pain, swelling, and nausea afterward. Forty adults having corrective jaw surgery will receive either ketamine plus standard anesthetic or standard anesthetic alone. Researche…
Sponsor: Bezmialem Vakif University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Could cannabis ease fibromyalgia pain? new trial investigates
Symptom relief OngoingThis study is testing a full-spectrum cannabis extract containing CBD and THC in 36 women with fibromyalgia, a condition causing widespread pain, fatigue, and sleep problems. Participants will receive different doses over six months to see if it improves symptoms and quality of l…
Phase 1/2 • Sponsor: Federal University of Latin American Integration • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Cochlear implant tuning gets personal: could Anatomy-Based settings boost hearing?
Symptom relief By invitation onlyThis study tests whether adjusting the frequency settings of a cochlear implant based on a person's ear anatomy can improve hearing and quality of life. Fifty new cochlear implant users with some hearing in their other ear will try two different settings and complete hearing test…
Sponsor: Med-El Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Cannabis compounds CBG and THC tested for pain and hunger boost
Symptom relief OngoingThis early study tests whether vaporized cannabigerol (CBG) and THC can help with pain and appetite. Twenty occasional cannabis users will receive different doses of CBG and THC, alone or together, and report their pain tolerance, hunger, and any side effects. The goal is to see …
Phase 1 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
Brain injury epilepsy study tests At-Home program to boost memory and ease caregiver burden
Symptom relief OngoingThis study tests a home-based program called HOBSCOTCH-PTE for people with epilepsy caused by a traumatic brain injury. The program aims to improve quality of life, memory, and thinking skills, and also helps support their caregivers. The study includes 160 adults with post-traum…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Breathing and pelvic floor exercises may offer Drug-Free period pain relief
Symptom relief By invitation onlyThis study looks at whether adding pelvic floor muscle exercises to deep breathing can help reduce pain during periods in women with primary dysmenorrhea. Forty women will be split into two groups: one doing both exercises, the other only deep breathing. Researchers will measure …
Sponsor: Istanbul Gelisim University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a High-Tech screen help stroke patients see the world again?
Symptom relief By invitation onlyThis study tests whether adding an interactive screen (MYRO) to standard therapy helps people who had a stroke and have trouble paying attention to one side of their world (left neglect). About 30 adults with a recent stroke will be split into two groups: one gets standard therap…
Sponsor: Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New study aims to bring affordable hearing help to korean american seniors
Symptom relief By invitation onlyThis study tests a hearing care program for older Korean Americans (age 60+) who have hearing loss but do not use hearing aids. The program includes a low-cost sound amplifier and communication training, delivered in the community. Researchers will compare participants who get th…
Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New sound tricks could help cochlear implant users hear better in noise
Symptom relief OngoingThis study tests experimental sound coding strategies that may improve hearing for adult cochlear implant users. About 120 participants will compare the new strategies to their current settings, focusing on understanding speech in noisy environments. The goal is to find ways to m…
Sponsor: Cochlear • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Buzzy bee takes the sting out of dental shots for kids
Symptom relief By invitation onlyThis study tests a device called Buzzy Bee that vibrates and cools the skin to distract children during a dental numbing shot. About 30 healthy kids aged 4-12 will try both the Buzzy Bee and standard care to see which hurts less. The goal is to make dental visits easier for child…
Sponsor: University of Jazan • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a common mineral cut opioid use after prostate surgery?
Symptom relief OngoingThis study tests whether giving magnesium sulfate during prostate surgery can lower pain and reduce the need for strong painkillers. About 68 adults having robotic prostate surgery will either receive magnesium or not, as part of their standard anesthesia. Researchers will compar…
Phase 4 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Drug-Releasing ear implant could boost hearing for millions
Symptom relief OngoingThis study tests a new cochlear implant that slowly releases a drug called dexamethasone to reduce swelling and tissue damage after surgery. The goal is to see if this helps the implant work better and improve hearing in adults with severe hearing loss. About 56 adults will recei…
Sponsor: Cochlear • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Zap to see: electrical therapy for eye disease
Symptom relief OngoingThis study tests a treatment called transcorneal electrical stimulation to see if it can improve vision in people with retinitis pigmentosa, an eye disease that causes vision loss. Twenty-one adults with the condition received the therapy, and researchers measured changes in thei…
Sponsor: Nova Southeastern University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Touch therapy: acupressure and massage may ease C-Section pain and fatigue
Symptom relief By invitation onlyThis study tests whether acupressure (applying pressure to specific points on the body) and back massage can reduce pain, fatigue, and improve sleep quality in women recovering from a cesarean section. About 111 new mothers will receive these non-drug treatments after surgery. Th…
Sponsor: Marmara University • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Can special goggles help Parkinson's patients see and feel better?
Symptom relief By invitation onlyThis study explores whether wearing prismatic goggles that shift vision can improve emotional awareness (alexithymia) and visual-spatial abilities in people with Parkinson's disease. Researchers will also use brain scans and tear tests to understand how the brain adapts and to fi…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Jaw pain study: could learning and simple exercises replace Hands-On therapy?
Symptom relief OngoingThis study tests whether a brief education and self-management program with home exercises can reduce pain and improve daily function in adults with long-lasting jaw pain (TMD) as effectively as more intensive hands-on physiotherapy. Forty adults aged 18–65 with jaw pain for at l…
Sponsor: Ciusss de L'Est de l'Île de Montréal • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Deaf seniors get a tailored workout to prevent falls
Symptom relief OngoingThis study tests an 8-week exercise program designed for deaf adults aged 60 and older. The classes are taught in American Sign Language and meet twice a week. Researchers will measure balance, leg strength, walking speed, and confidence to see if the program helps reduce fall ri…
Sponsor: Gallaudet University • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New painkiller aims to cut opioid use after shoulder surgery
Symptom relief By invitation onlyThis study tests whether a medication applied directly during shoulder replacement surgery (ZYNRELEF) can reduce the need for strong painkillers after the operation, compared to the standard method of using a nerve block with a catheter. About 86 adults having shoulder replacemen…
Phase 4 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Pain relief showdown: injection vs. patch for back and neck pain
Symptom relief CancelledThis study aimed to see if a lidocaine injection or a lidocaine patch works better for muscle pain in the neck and back. It was designed for adults visiting the emergency department. However, the study was withdrawn before any participants were enrolled.
Phase 4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Knee replacement recovery: could a steroid taper help?
Symptom relief CancelledThis study planned to test whether a 6-day course of oral methylprednisolone after total knee replacement could improve pain, sleep, and knee movement. Participants would also receive a steroid injection during surgery. The study was withdrawn before enrolling anyone, so no concl…
Phase 4 • Sponsor: F. Johannes Plate • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Yoga vs. nerve pain: could stretching replace pills for chemo side effects?
Symptom relief OngoingThis study tests whether yoga can reduce nerve pain caused by chemotherapy in cancer survivors. About 227 participants will either take yoga classes twice a week for 8 weeks, attend educational sessions, or receive standard care. Researchers will measure pain, balance, fall risk,…
Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Could a water shot beat morphine for kidney stone pain?
Symptom relief OngoingThis study compares a simple sterile water injection into the skin with intravenous morphine for relieving severe kidney stone pain. 150 adults with confirmed stones and high pain levels will receive either one or four water injections or morphine. Pain is measured over 90 minute…
Sponsor: University Tunis El Manar • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Pre-surgery pain class may ease joint replacement recovery
Symptom relief By invitation onlyThis study tests whether giving patients a pain education booklet and video before knee or hip replacement surgery helps them feel less anxious and have less pain afterward. About 70 adults scheduled for elective joint replacement will be randomly assigned to receive the educatio…
Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Sound waves aimed at the brain could ease seizures
Symptom relief By invitation onlyThis small study tests whether low-intensity focused ultrasound (LIFU) can safely reduce seizures in people with temporal lobe epilepsy that doesn't improve with medication. Six participants with implanted brain electrodes will receive both real and sham ultrasound sessions. The …
Sponsor: Carilion Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Painkiller study pulled before it even started
Symptom relief CancelledThis study aimed to see if a tiny dose of buprenorphine/naloxone (a medicine used for opioid addiction) could help control pain after surgery in people who already take strong painkillers. It was designed for adults having orthopedic or general surgery. However, the study was wit…
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New study aims to find best pain relief for hip surgery patients
Symptom relief OngoingThis study looks at two different nerve-block methods to control pain after hip surgery. One group gets a standard block that numbs the hip joint, while the other gets an extra block for the thigh skin. The goal is to see which method reduces pain, lowers the need for pain medici…
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can hearing aids and tinnitus maskers silence the ringing?
Symptom relief By invitation onlyThis study is testing whether hearing aids alone or hearing aids with a tinnitus masker can improve hearing and reduce tinnitus symptoms in adults with hearing loss and tinnitus. One hundred participants will wear hearing aids for 6 months, with the masker turned on after 3 month…
Sponsor: Starkey Laboratories, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Shock therapy for needle jitters: AcuTENS tested in prostate biopsy
Symptom relief OngoingThis study tests whether a gentle electrical current applied to specific points on the skin (AcuTENS) can reduce pain and anxiety during a prostate biopsy. About 53 men having their first biopsy will receive either active AcuTENS or a placebo device, on top of standard numbing me…
Sponsor: University of Malaya • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Promising sound therapy trial for ringing ears pulled before it began
Symptom relief CancelledThis study aimed to test a closed-loop sound therapy for people with chronic tinnitus (ringing in the ears) or hyperacusis (sensitivity to sound). The therapy was designed to retrain the brain's response to sounds. However, the trial was withdrawn before any participants were enr…
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can a tablet app help deaf kids talk better?
Symptom relief OngoingThis study tests whether using special communication technology (AAC) alongside speech therapy helps children who are deaf or hard of hearing develop language faster. Half of the 154 children will use AAC tools, while the other half continue their usual therapy. Researchers will …
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New wash may ease pain and nausea after gallbladder surgery
Symptom relief OngoingThis study tests whether adding the anti-nausea drug ondansetron to a standard saline wash during gallbladder surgery can better control pain and nausea afterward. Forty adults having their gallbladder removed will be randomly assigned to receive either a plain saline wash or one…
Phase 4 • Sponsor: Instituto Mexicano del Seguro Social • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Which numbing drug works best for dialysis access surgery?
Symptom relief OngoingThis study tests two numbing medicines, ropivacaine and lidocaine, in 40 adults with end-stage kidney disease who need surgery to create a blood vessel connection (fistula) for dialysis. Patients are randomly assigned to receive one of the two drugs during surgery, and neither th…
Phase 4 • Sponsor: The First People's Hospital of Lianyungang • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Ancient exercises may boost balance and mood in deaf community
Symptom relief By invitation onlyThis study looks at whether traditional exercises like Tai Chi and Baduanjin can help people with hearing loss feel better physically and mentally. About 90 adults with severe hearing loss will be split into three groups: one doing Tai Chi, one doing Baduanjin, and one doing regu…
Sponsor: Northeast Normal University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Which pain block works best after mastectomy? new study aims to find out
Symptom relief OngoingThis study compares two types of nerve blocks (PECS II-PIFB vs. SAPB) to see which provides better pain relief for women undergoing modified radical mastectomy. Seventy women aged 18-65 will be enrolled, and the main goal is to measure how much extra pain medicine they need in th…
Sponsor: Assiut University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Ancient exercises tested for vision loss health boost
Symptom relief By invitation onlyThis study looks at whether traditional exercises like Tai Chi and Baduanjin can help visually impaired university students improve their balance, mood, and quality of life. Ninety participants will be split into three groups: Tai Chi, Baduanjin, or regular physical education cla…
Sponsor: Northeast Normal University • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Acupuncture showdown: which needle works best for chronic pain?
Symptom relief OngoingThis study compares personalized electro-acupuncture and auricular-acupuncture against usual care for treating chronic pain in adults with musculoskeletal pain or fibromyalgia. Participants are split into three groups: two receive different acupuncture methods, and one receives s…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New program aims to ease chronic pain for those who care for others
Symptom relief OngoingThis study tests a program called COMPASS-NP for home care workers who have chronic pain. The program combines pain education, coping strategies, and safety tips, led by a trained peer. About 140 workers will take part to see if it reduces how much pain interferes with their work…
Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Tailbone pain study tests two procedures for better relief
Symptom relief OngoingThis study compares two procedures to relieve chronic tailbone pain (coccydynia) that is not related to cancer. About 74 adults aged 20-70 who have not responded to standard medical treatment will be split into two groups. One group will receive conventional radiofrequency ablati…
Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Hearing aid showdown: lexie B3 pro vs. competitor in new study
Symptom relief CancelledThis study aimed to compare two over-the-counter hearing aids—the Lexie B3 Pro and a competitor—in adults with mild to moderate hearing loss. Participants would have tested each device and reported their experiences. However, the trial was withdrawn before any participants were e…
Sponsor: HearX SA • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New study tests if Over-the-Counter hearing aids work as well as prescription ones
Symptom relief CancelledThis study aims to see if a self-fitting over-the-counter (OTC) hearing aid works as well as a professionally fitted prescription device for adults with mild-moderate hearing loss. The research involves three phases: validating a hearing test, checking user experience, and a rand…
Sponsor: HearX SA • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Placebo power: cutting opioids without extra pain
Symptom relief OngoingThis study tests a method called conditioning open-label placebo (COLP) to help patients with spinal cord injury, multiple injuries, or burns use fewer opioids while still getting the same pain relief. About 66 adults in intensive rehab will receive a placebo alongside their regu…
Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Acupuncture may slash opioid use in cancer patients
Symptom relief OngoingThis study tests whether adding acupuncture to standard pain care can reduce the need for strong opioid painkillers in people with multiple myeloma, Hodgkin disease, or non-Hodgkin lymphoma who are getting high-dose chemotherapy. About 299 adults will be randomly assigned to rece…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New device may cut opioid use after Open-Heart surgery
Symptom relief By invitation onlyThis study looks at whether using Montage or Montage-CT devices to close the breastbone after heart surgery can lower the need for strong painkillers like opioids. Researchers will review records from 150 adults who had planned heart surgery. They will compare opioid use and reco…
Sponsor: Abyrx, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could migraine pills silence ringing ears? new trial investigates
Symptom relief OngoingThis study tests whether common migraine medications can reduce the impact of sudden tinnitus (ringing in the ears) in 100 adults aged 25 to 85. Participants receive the drugs and complete questionnaires about their symptoms, plus brain scans to look for changes. The goal is to f…
Phase 4 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Glasses that see seizures coming: new wearable aims to predict epilepsy attacks
Symptom relief OngoingThis study tests a pair of smart glasses called NEXA that can read brain signals through dry electrodes. The glasses aim to predict epileptic seizures in real time and alert the wearer with vibrations, lights, or sounds. Researchers will test the device on 47 adults with epilepsy…
Sponsor: Oman Ministry of Health • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Could a common Alzheimer's drug help people hear better with cochlear implants?
Symptom relief OngoingThis early-phase study tests whether donepezil, a drug used for Alzheimer's, can improve speech recognition in adults who already use a cochlear implant. Researchers think the drug may help the brain adapt to the implant's signals. Fifty participants will receive either donepezil…
Early phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Spinning chair could stop vertigo faster for BPPV patients
Symptom relief OngoingThis study tests two different head-and-body rotation procedures done in a mechanical chair to treat a common inner-ear condition called BPPV, which causes brief but intense spinning sensations. 128 adults with confirmed BPPV will be randomly assigned to either the standard Epley…
Sponsor: Aalborg University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Cannabis oil shows promise for fibromyalgia sufferers
Symptom relief OngoingThis study looks at whether cannabis oil can help reduce pain and improve sleep and quality of life in people with fibromyalgia who have not found relief from other treatments. Researchers will track pain levels, side effects, and how well patients stick to the treatment. The goa…
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Virtual reality hypnosis tested as Drug-Free labor pain relief
Symptom relief By invitation onlyThis study tests whether using a virtual reality headset (HypnoVR) can help reduce pain and anxiety during labor. Seventy women in Tunis will be randomly assigned to use the headset or receive standard care. Researchers will measure pain and anxiety levels before and after the in…
Sponsor: University Tunis El Manar • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Could a common steroid make gallbladder surgery recovery less painful?
Symptom relief OngoingThis study tests whether adding dexamethasone (a steroid) to a standard numbing injection (TAP block) can improve pain control after laparoscopic gallbladder removal. About 100 adults will receive either the standard numbing medicine or the numbing medicine plus dexamethasone. Th…
Phase 1 • Sponsor: Makassed General Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 19:19 UTC
-
Kaleidoscope calms kids with cancer during needle pokes
Symptom relief OngoingThis study tests whether using a kaleidoscope can reduce pain, anxiety, and fear in children aged 6-14 with cancer who are getting subcutaneous injections. The kaleidoscope is used as a distraction during the procedure. The study involves 72 children and compares their pain and f…
Sponsor: Zubeyde Ezgi Ercelik • Aim: Symptom relief
Last updated Jun 26, 2026 14:29 UTC
-
Can a dementia drug silence ringing ears?
Symptom relief OngoingThis study tests whether donepezil, a drug used for dementia, can help people with chronic tinnitus (ringing in the ears). 70 adults with long-term tinnitus received either donepezil or a placebo for 3 months. Researchers measured changes in tinnitus severity using standard quest…
Phase 4 • Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 26, 2026 14:20 UTC
-
Can a nerve zap or a neck stretch silence the ringing in your ears?
Symptom relief OngoingThis study tests two simple, drug-free treatments for chronic tinnitus (ringing in the ears) that hasn't improved with standard medical care. 45 adults will be split into three groups: one gets 10 sessions of mild electrical stimulation to a nerve in the ear, another does specifi…
Sponsor: Necmettin Erbakan University • Aim: Symptom relief
Last updated Jun 26, 2026 14:05 UTC
-
New toolkit aims to ease pain in nursing homes without drugs
Symptom relief By invitation onlyThis study tests a pain management toolkit for nursing home residents. The toolkit includes non-drug methods like massage, relaxation, exercise, music, and aromatherapy. Researchers will see if it helps staff manage pain better and improves residents' comfort and quality of life.…
Sponsor: Medizinische Universität Graz, Institut für Pflegewissenschaft • Aim: Symptom relief
Last updated Jun 26, 2026 13:36 UTC
-
Scientists track eye disease progression over five years
Knowledge-focused OngoingThis study follows 110 people who previously took part in the AREDS or AREDS2 trials to see how age-related macular degeneration (AMD) and cataracts change over time. Participants get a yearly eye exam, including vision tests and eye photos, and may give a blood sample. The goal …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
10-Year NF1 study aims to unlock secrets of rare genetic disorder
Knowledge-focused OngoingThis natural history study follows 259 children, adolescents, and adults with Neurofibromatosis Type 1 (NF1) for up to 10 years. Researchers will track tumor growth, monitor quality of life, and perform genetic testing to better understand how the disease changes over time. The g…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain training game aims to restore sight after stroke
Knowledge-focused By invitation onlyThis study tests a new computer-based visual training task for people who have lost part of their vision due to a stroke. Participants watch moving patterns on a screen and learn to detect motion direction, with the goal of improving visual abilities. The study first checks if th…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Eye disease progression under the microscope: 3-Year study launched
Knowledge-focused OngoingThis study follows 400 people with intermediate age-related macular degeneration (AMD) for about 3 years. Researchers watch how the disease advances to more severe stages and test if measuring the loss of light-sensing cells in the eye can be a useful way to track the disease. No…
Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists map how noise blurs speech across frequencies
Knowledge-focused By invitation onlyResearchers at Ohio State University are studying how background noise affects speech understanding in adults with normal hearing. About 200 native English speakers aged 18 to 70 will listen to filtered speech in different frequency ranges while noise is added at various levels. …
Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Apple watch could predict brain tumor complications
Knowledge-focused PausedThis study explores whether an Apple Watch can track walking, heart rate, breathing, and sleep in people with glioblastoma, a serious brain cancer. The goal is to see if the watch can detect symptom changes before they become serious, like seizures or blood clots. Twenty-five pat…
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Epilepsy's hidden toll on the heart and lungs: a clue to sudden death?
Knowledge-focused OngoingMayo Clinic researchers are studying whether epilepsy changes how the body controls blood pressure, heart rate and breathing, and whether those changes relate to the risk of sudden unexpected death in epilepsy (SUDEP). The study enrolls adults aged 18 to 90 with epilepsy who can …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Which epidural technique best handles a cesarean emergency?
Knowledge-focused By invitation onlyResearchers at Mayo Clinic are reviewing records from 1,500 women who had an epidural for labor pain and then needed a cesarean delivery. They are comparing three epidural placement techniques: traditional epidural, dural puncture epidural (DPE), and combined spinal-epidural (CSE…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Massive Real-World study tracks roche eye drugs in 6,000 patients
Knowledge-focused OngoingThis study is collecting long-term, real-world data from about 6,000 adults being treated with Roche eye medications (Faricimab or the Port Delivery System with Ranibizumab) for conditions like wet age-related macular degeneration and diabetic macular edema. The goal is to unders…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a different anesthesia approach tame inflammation after chest surgery?
Knowledge-focused OngoingThis study looks at two ways of managing anesthesia during non-intubated video-assisted thoracoscopic surgery (NIVATS), a type of chest surgery where patients breathe on their own without a breathing tube. Researchers will review records of 120 adults who had this surgery to crea…
Sponsor: Koşuyolu Kartal Heart Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New eye imaging could reveal hidden clues to vision loss
Knowledge-focused By invitation onlyThis study explores whether combining three eye-imaging techniques can reveal how structural damage in the retina relates to vision loss in people with geographic atrophy, a form of age-related macular degeneration. Researchers will use OCT scans, ultra-high-resolution AOSLO imag…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists track rare eye disease to prepare for future treatments
Knowledge-focused OngoingThis study follows 68 people aged 12 and older who have ABCA4 gene mutations, which can cause vision loss from diseases like Stargardt disease. Over 10 years, researchers will collect blood and skin samples and perform detailed eye exams to understand how the disease progresses. …
Sponsor: National Eye Institute (NEI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New sign language teaching method put to the test in schools
Knowledge-focused OngoingThis study looks at whether a special training program for teachers can help deaf children learn sign language better. About 150 teachers and their deaf students (ages 4-12) are taking part. Teachers are split into two groups: one gets the new training, the other continues as usu…
Sponsor: The University of Tennessee, Knoxville • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Scientists zap brains to boost memory in epilepsy patients
Knowledge-focused By invitation onlyThis study looks at how the brain creates and recalls memories by recording brain activity in people with epilepsy who already have electrodes placed for surgery. Participants play memory games on a laptop while their brain signals are recorded, and sometimes small electrical pul…
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
6,000 patients, one big question: what really causes dizziness?
Knowledge-focused OngoingThis observational study will follow 6,000 adults with dizziness or vertigo who are receiving routine care at hospitals across China. Researchers aim to map the range of underlying causes, track how symptoms and diagnoses change over a year, and see how well standard treatments w…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
AI could turn bionic eyes into smart vision for the blind
Knowledge-focused By invitation onlyThis study tests whether AI-powered software can improve the usefulness of artificial vision for people with visual prostheses (bionic eyes). The goal is to help users better understand what they see by enhancing the visual scene, similar to augmented reality. Participants will p…
Sponsor: University of California, Santa Barbara • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
New program aims to bridge hearing care gap in rural kentucky
Knowledge-focused OngoingThis study tests a patient navigation program to help rural adults in Kentucky get hearing tests. 500 participants from primary care clinics will receive guidance every two weeks to overcome barriers like travel and cost. The goal is to see if more people complete diagnostic hear…
Sponsor: Matthew Bush, MD • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can switching visual tasks sharpen or slow your search?
Knowledge-focused OngoingThis study investigates whether performing the same visual search task repeatedly in a block changes how people search compared to when tasks are randomly mixed. Healthy adults with normal color vision will complete four search tasks where the target stays the same but distractor…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Scientists track rare eye disease to uncover clues for future treatments
Knowledge-focused OngoingThis study follows 46 people with gyrate atrophy, a rare genetic condition that causes vision loss, over 4 years. Researchers measure ornithine levels in the blood and track changes in the retina using eye scans and photos. The goal is to learn how the disease progresses under st…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New study tracks Faricimab's Real-World impact on major eye diseases
Knowledge-focused OngoingThis study follows 1,000 patients in China who are already receiving faricimab for diabetic macular edema, retinal vein occlusion, or wet age-related macular degeneration. Researchers will collect data from routine clinic visits over one year to see how well the drug works and ho…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Smart sensors could predict falls in older adults with dizziness
Knowledge-focused By invitation onlyThis study evaluates a sensor-based version of the Timed Up and Go test (QTUG) for measuring balance and predicting fall risk in older adults with dizziness (vestibulopathy). Researchers will compare QTUG results with other balance tests, track whether a six-month vestibular reha…
Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
New program helps parents of deaf kids handle behavior challenges
Knowledge-focused OngoingThis study looks at whether a special parent training program can help families with deaf or hard of hearing children aged 3 to 6. The program teaches positive parenting strategies to prevent behavior problems. About 295 parents will take part, and researchers will measure change…
Sponsor: Christina Studts • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Eye disease study aims to pave way for future treatments
Knowledge-focused OngoingThis study follows 127 people with a genetic eye condition called USH2A-related retinal degeneration, which can cause vision loss and hearing problems. Researchers measure changes in vision, retinal sensitivity, and mobility over several years. The goal is to understand how the d…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Study tests if lowering beeping alarms eases brain strain for trainee surgeons
Knowledge-focused OngoingThis study looks at whether turning down the volume of anesthesia alarms can help surgical trainees think more clearly during practice surgeries. About 26 surgeons-in-training will perform simulated procedures with either standard or quieter alarms. Researchers will measure menta…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Spinal anesthesia during C-Section may affect hearing, study suggests
Knowledge-focused OngoingThis study looks at whether spinal anesthesia used during planned cesarean deliveries can cause temporary hearing loss. Researchers will test women's hearing before and after the procedure using a standard hearing test. They will also track headaches that can occur after spinal a…
Sponsor: Duzce University • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Eye drug faricimab under the microscope: Real-World data collection begins
Knowledge-focused OngoingThis study is collecting information from 850 people with wet age-related macular degeneration or diabetic macular edema who are being treated with faricimab (VABYSMO) in routine clinical practice. Over two years, researchers will track vision changes, treatment schedules, and sa…
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Real-World check: does aflibercept 8 mg hold up outside the lab?
Knowledge-focused OngoingThis observational study will follow 2,500 adults with vision loss from nAMD or DME who are already prescribed aflibercept 8 mg by their doctors. Researchers will collect data from routine visits over up to 24 months to see how vision changes. The goal is to understand how well t…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Withdrawn study sought better way to time eye injections
Knowledge-focused CancelledThis study aimed to see if how well a person can fix their gaze relates to signs of active disease on eye scans in patients with age-related macular degeneration (ARMD) treated with antiVEGF injections. Researchers planned to follow patients for two years, measuring fixation qual…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Scientists track Long-Term safety of experimental AMD therapy
Knowledge-focused By invitation onlyThis study follows people with advanced dry age-related macular degeneration who previously received a one-time injection of the experimental treatment VOY-101. Researchers are monitoring participants over the long term to check for any side effects related to the treatment. The …
Sponsor: Perceive Biotherapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New study tracks stargardt disease to pave way for future treatments
Knowledge-focused OngoingThis study follows 80 people aged 8 to 50 with Stargardt disease, a genetic eye condition that causes vision loss. Researchers will monitor how the disease changes over time using eye imaging. The goal is to better understand the disease and prepare for future clinical trials.
Sponsor: AAVantgarde Bio Srl • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Knee replacement avoided? study tests 3-Month exercise and diet program
Knowledge-focused By invitation onlyThis study looks at whether a 3-month non-surgical program—including patient education, supervised exercise, and diet counseling—can help people with knee osteoarthritis avoid knee replacement surgery while maintaining their quality of life. Researchers will follow 2,500 patients…
Sponsor: Marius Henriksen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Ground-Level vision test could help retinitis pigmentosa patients walk better
Knowledge-focused CancelledThis study was designed to see if a new method of measuring the visual field—by projecting vision zones on the ground—helps people with retinitis pigmentosa understand their remaining sight and improve their walking rehabilitation. The trial was withdrawn before enrolling any par…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Scientists watch how dizzy patients walk to uncover hidden clues
Knowledge-focused By invitation onlyThis study looks at how people with long-term dizziness (chronic vestibulopathy) walk and keep their balance, comparing them to healthy volunteers. Researchers will measure things like step length, sway, and fear of falling using special equipment and tests. The goal is to better…
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Toddler talk time: early coaching for deaf kids may pay off years later
Knowledge-focused By invitation onlyThis study follows 88 deaf or hard-of-hearing children who, as toddlers, were randomly assigned to receive a 6-month parent coaching program or standard care. Researchers want to see if the early coaching leads to better language, reading, and social skills when the children reac…
Phase 2 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to tackle vision problems in upper manhattan
Knowledge-focused CancelledThis study aims to help adults aged 40 and older in Upper Manhattan get better eye care. It will offer free eye screenings at local health centers and senior centers, and provide support like scheduling appointments and transportation. The goal is to see if this extra help leads …
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Eggs on the menu: could a daily dozen slow vision loss?
Knowledge-focused OngoingThis pilot study tests whether older adults with intermediate age-related macular degeneration (AMD) can eat 2 or 4 whole eggs daily for 5 months. The main goal is to see if people can stick with the diet, not to prove eggs improve vision. Researchers will also measure changes in…
Early phase 1 • Sponsor: Kathryn Starr • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Ultrasound-Guided epidurals: a missed opportunity?
Knowledge-focused CancelledThis study aimed to see if using real-time ultrasound during a thoracic epidural block makes the procedure more reliable. It was designed for adults with chest or abdominal pain or rib fractures. The study was withdrawn before enrolling any participants, so no results are availab…
Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Japanese database study tracks Real-World use of eye injection aflibercept 8 mg
Knowledge-focused OngoingThis observational study examines how aflibercept 8 mg, an injection into the eye, is used in routine care for patients in Japan with age-related macular degeneration or diabetic macular edema. Researchers will analyze claims data from about 3000 patients to understand patient ch…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Brain scans reveal Fentanyl's signature in real time
Knowledge-focused By invitation onlyThis study looks at how fentanyl changes brain activity using EEG (a brain wave test) in 20 adults having surgery. Researchers want to find a specific brain signal linked to fentanyl and see if it relates to how much people like the drug. No new treatment is tested—only brain pat…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Spinal morphine under the microscope: new study aims to reduce side effects
Knowledge-focused OngoingThis study looks back at the medical records of 600 adults who received a single shot of morphine into the spine before surgery. The goal is to understand how often side effects like breathing problems, itching, and nausea happen. By learning more, doctors hope to make pain manag…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
10,000 people to have eye and skin pigments measured in nutrition study
Knowledge-focused By invitation onlyThis study aims to understand how diet affects the eyes and skin by measuring natural pigments called carotenoids. Researchers will use non-invasive methods to check levels in the eye and skin, and also test blood in some participants. Anyone age 7 or older having a routine eye e…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could light make cochlear implants hear better?
Knowledge-focused By invitation onlyThis study tests a new type of cochlear implant that uses light instead of electricity to stimulate the hearing nerve. Researchers hope light can target smaller nerve groups, leading to clearer sound. The trial involves 30 adults who are already having ear surgery for tumor remov…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Personalized hearing aid settings put to the test
Knowledge-focused By invitation onlyThis study looks at whether hearing aids programmed to match a person's unique listening style can improve speech understanding in noisy environments. Thirty adults with sensorineural hearing loss will attend a 2-hour lab visit, where they will listen to sentences in noise with b…
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New eye tests could speed up retinitis pigmentosa treatment trials
Knowledge-focused OngoingThis study aims to find better ways to measure how retinitis pigmentosa (a genetic eye disease that causes vision loss) progresses over time. Researchers will use advanced imaging and vision tests in 40 people with specific genetic forms of the disease. The goal is to identify re…
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Why do some blind people see things that Aren't there? new study aims to find out
Knowledge-focused By invitation onlyThis study looks at how common Charles Bonnet Syndrome (CBS) is in people with vision loss from conditions like macular degeneration or glaucoma. CBS causes complex visual hallucinations without mental illness. Researchers will survey 640 participants to measure how often it happ…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Eye fluid test could spot dry AMD changes early
Knowledge-focused OngoingThis study is testing whether taking a tiny sample of fluid from the front of the eye is safe for people with dry age-related macular degeneration (AMD). Researchers will analyze proteins in the fluid to see if they change over time. The study includes 50 adults aged 50 to 89, so…
Sponsor: ClinOmicsAI • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New study aims to spot sight problems in older fall patients
Knowledge-focused OngoingThis study looks at how to better check vision in older adults (65+) who come to the hospital after a fall. Falls are common and costly, and poor eyesight can double the risk of falling again. Researchers will talk to patients, carers, and health professionals to develop a practi…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Can't smell or hear? study links sensory loss to brain decline over 5 years
Knowledge-focused OngoingThis study follows 100 people aged 60-85 with mild memory or movement problems to see if losing smell, hearing, or balance speeds up cognitive decline. Researchers will test these senses and track thinking skills and quality of life for 5 years. The goal is to understand which se…
Sponsor: University of Campania Luigi Vanvitelli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Your DNA could determine how well anesthesia works
Knowledge-focused OngoingThis study looks at how small differences in certain genes affect how people respond to propofol, a common anesthesia drug. Researchers want to understand why some people wake up faster or have more side effects than others. The goal is to help doctors give safer, more personaliz…
Sponsor: Superior University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
HIV-Exposed Kids' hearing under scrutiny in withdrawn study
Knowledge-focused CancelledThis study aimed to understand how exposure to HIV and antiretroviral therapy in the womb might affect hearing in children who are HIV-free. Researchers planned to test hearing abilities in healthy infants born full-term. However, the study was withdrawn before enrolling any part…
Sponsor: San Diego State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Walking test could revolutionize scoliosis checks in kids
Knowledge-focused OngoingThis study aims to develop a new way to measure how the spine moves during walking in children, both healthy and those with scoliosis. Researchers will use a special camera system and reflective markers placed on the skin to track movement. The goal is to create a reliable and ea…
Sponsor: IRCCS Eugenio Medea • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Scientists track vision loss in rare genetic eye disease to pave way for future treatments
Knowledge-focused OngoingThis study follows 50 people with a rare inherited eye condition called PRPF31-related retinal dystrophy (RP11) to see how their vision changes over time. Researchers will measure things like visual acuity, retinal thickness, and quality of life using eye exams and questionnaires…
Sponsor: PYC Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Eye disease study lays groundwork for gene therapy breakthrough
Knowledge-focused PausedThis study looks at a rare, inherited eye disease called CNGB1 retinitis pigmentosa that causes gradual vision loss and blindness. Researchers want to learn how the disease progresses by using eye exams and imaging tests over three years. The goal is to find the best ways to meas…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can your eyes reveal pain? new device aims to end opioid guesswork
Knowledge-focused OngoingThis study tests a device that uses changes in pupil size to measure pain and how well opioid painkillers are working. The goal is to replace subjective pain scores with an objective measurement, helping doctors prescribe opioids more safely. The study includes 40 children and yo…
Sponsor: Julia Finkel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
300,000 iPhone users join Apple's landmark hearing study
Knowledge-focused OngoingThis study, run by Apple and the University of Michigan, tracks headphone and environmental sound exposure in 300,000 US adults using iPhones and Apple Watches. Participants answer surveys and take hearing tests through the Research app. The goal is to understand how everyday sou…
Sponsor: Apple Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Massive PT study mines 4 million records to find what works best
Knowledge-focused OngoingThis study looks back at the medical records of about 4 million people who had physical or occupational therapy for muscle and joint problems. Researchers want to see if different ways of giving therapy lead to different results. No new treatments are tested—the goal is to learn …
Sponsor: ATI Holdings, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New cochlear trick may boost hearing without longer implants
Knowledge-focused OngoingThis study tests a new technique that lets a cochlear implant stimulate the entire cochlea without needing a longer electrode. The goal is to see if this improves speech understanding and sound quality for people with hearing loss. About 40 adults who already qualify for a cochle…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Eye disease study seeks better ways to measure sight loss
Knowledge-focused OngoingThis study follows 12 adults with severe retinitis pigmentosa, a genetic eye disease that causes vision loss. Researchers want to find out which vision tests people with very low sight can reliably perform and how their vision changes over one year. The goal is to improve future …
Sponsor: Sumitomo Pharma America, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Film class may boost med student empathy, study says
Knowledge-focused By invitation onlyThis study looks at whether a 14-week elective course that uses films and discussions about social justice can help medical students better understand their own emotions and feel more empathy for others. About 60 medical students will take part, with some taking the course and ot…
Sponsor: Çanakkale Onsekiz Mart University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Simple balance tests may pinpoint why you feel dizzy
Knowledge-focused OngoingThis study looks at whether common balance tests can tell doctors why a person is having trouble with balance. Researchers will test 330 people, including healthy volunteers and patients with stroke, vision problems, inner ear issues, spine problems, or spinal cord damage. The go…
Sponsor: Military Institute od Medicine National Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Healthy volunteers help unlock secrets of vision recovery
Knowledge-focused OngoingThis study looks at how the brain changes and adapts after losing central vision, which happens in conditions like macular degeneration. Researchers are testing different training tasks in 120 healthy adults aged 18-30 to measure improvements in eye movements and focus. The goal …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can brain wave patterns predict epilepsy after a stroke?
Knowledge-focused OngoingThis study followed 602 people who had a stroke to see how many later had seizures. Researchers looked at blood tests, brain scans, and EEG recordings to find clues that might predict who is at risk. The goal is to better understand why some stroke survivors develop epilepsy.
Sponsor: University Medical Centre Maribor • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Tiny brain tracker could help spot hidden seizures in people with intellectual disabilities
Knowledge-focused OngoingThis study looks at whether a tiny device placed under the scalp can safely and comfortably track seizures in adults with mild to moderate intellectual disability and epilepsy. Nine participants will wear the monitor for up to 6 months, and researchers will compare the device's r…
Sponsor: University of Plymouth • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Scientists map rare blindness to speed future cures
Knowledge-focused OngoingThis study follows 44 people with a rare genetic form of Usher syndrome caused by PCDH15 mutations. Over 48 months, researchers measure how their vision changes using eye exams and imaging. The goal is to identify the best ways to track disease progression, which will help design…
Sponsor: Jaeb Center for Health Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Pupil dilation may reveal secrets of hearing nerve
Knowledge-focused By invitation onlyThis study looks at how stimulating a nerve in the ear affects pupil size during cochlear implant surgery. Researchers will measure pupil dilation in 30 adults to learn more about the vagus nerve's role in hearing. The goal is to gather knowledge, not to treat hearing loss direct…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Wearable tech aims to track rare brain diseases from home
Knowledge-focused OngoingThis study is testing whether wearable sensors can reliably monitor movement problems in people with progressive supranuclear palsy (PSP) and related frontotemporal disorders. About 60 participants will wear pendant-like devices for 12 months to track their activity. The goal is …
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Walking study pulled before it even started
Knowledge-focused CancelledThis study was designed to see if changing the sound of your own footsteps—by making them louder or softer—could affect how stable you are while walking. The researchers planned to test healthy adults who could walk for 30 minutes. However, the study was withdrawn before enrollin…
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can remote check-ups replace clinic visits for cochlear implant patients?
Knowledge-focused OngoingThis study looks at whether managing cochlear implant care remotely (via phone or app) works as well as going to the clinic. About 148 adults with hearing loss will be followed for a year after their implant is activated. The goal is to see if remote care saves time and money whi…
Sponsor: Cochlear • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Brain zap study hopes to restore sight in the blind
Knowledge-focused OngoingThis study tests whether stimulating the visual part of the brain can create visual sensations in blind volunteers. Five adults who are blind will have a device implanted in their skull to deliver tiny electrical pulses. The goal is to learn where and how much stimulation is need…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Can a simple doctor visit help underserved seniors hear better?
Knowledge-focused OngoingThis study tests a hearing program for older adults who don't have easy access to hearing care. During a primary care visit, participants are screened for hearing loss and then randomly assigned to either get counseling on affordable listening devices or be referred to standard a…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
AI trained to predict pain in toddlers after day surgery
Knowledge-focused OngoingThis study tests whether a computer program (machine learning) can predict pain in children aged 1 to 3 after day surgery. Researchers will record details like age, weight, and parent anxiety before surgery, then note the child's pain scores and vital signs after surgery. No extr…
Sponsor: Başakşehir Çam & Sakura City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New epilepsy drug candidate iQ-007 enters first human safety trial
Knowledge-focused OngoingThis early-stage trial tests the safety of an experimental oral drug called iQ-007 in 72 healthy volunteers. The drug is designed to help control seizures by boosting the brain's ability to clear excess glutamate, a chemical linked to epilepsy. The study does not yet test if it w…
Phase 1 • Sponsor: iQure Australia Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Pain management study pulled before it even started
Knowledge-focused CancelledThis study aimed to see if a team of doctors, nurses, and pharmacists working together could help people recover better after anorectal surgery. It planned to compare standard care with this team-based approach in 126 adults. However, the study was withdrawn before any participan…
Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Brain-Training games aim to boost hearing in crowds
Knowledge-focused CancelledThis study planned to test whether playing specially designed video games at home could improve the ability of older adults with high-frequency hearing loss to understand speech in noisy environments. Participants would have played either an immersive audiomotor game or an audito…
Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Hidden blood vessels may shield eyes from blindness, new study suggests
Knowledge-focused OngoingThis study looks at a specific type of blood vessel growth under the retina, called non-exudative type 1 macular neovascularization (MNV), in people with age-related macular degeneration (AMD). Researchers want to see if these vessels actually help preserve vision rather than har…
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Could a workout save your sight? new study investigates
Knowledge-focused OngoingThis study aims to find out if changes in blood markers can predict whether exercise helps improve vision. Researchers will compare aerobic exercise to balance training in 14 sedentary adults aged 18 to 89 with vision disorders. The goal is to understand how exercise might protec…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Stroke vision loss: brain training shows promise in new study
Knowledge-focused OngoingThis study looks at how the brain's visual system changes in the year after a stroke that damages the vision center. Researchers will measure vision and brain structure over time, and give participants a home-based computer training program that asks them to detect moving dots. T…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New study tracks sign language progress in deaf kids
Knowledge-focused OngoingThis study looks at how deaf children in kindergarten through 3rd grade develop sign language skills. Eight children from a school for the deaf will receive special sign instruction and have their language progress tracked daily. The goal is to understand how teaching methods aff…
Sponsor: The University of Tennessee, Knoxville • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Study seeks to uncover barriers to vision care for special needs kids
Knowledge-focused By invitation onlyThis study looks at the eye care needs of children and adolescents with special needs, who are much more likely to have vision problems than other kids. Researchers will interview parents and teachers to find out what makes it hard or easy to get eye care. The goal is to identify…
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Mayo clinic launches major brain disease tracking study
Knowledge-focused By invitation onlyThis study aims to learn more about diseases that affect the brain, such as Parkinson's disease and different types of dementia. Researchers will follow 500 adults with symptoms of these conditions over time, using brain scans and genetic tests to see how the diseases progress. T…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
300 patients tracked after eye disease treatments – what really happens?
Knowledge-focused OngoingThis study follows 300 patients with chronic eye conditions like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy who recently received treatment. Researchers will measure changes in eye pressure, vision, and other outcomes over time. The goal is to unde…
Sponsor: Interstat LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Free eye tests aim to catch vision loss early in harlem and washington heights
Knowledge-focused OngoingThis study offers free vision screenings to underserved adults over 40 living in affordable housing in Harlem and Washington Heights. The goal is to find eye problems like glaucoma, cataracts, and diabetic retinopathy early and connect people with follow-up care. About 749 partic…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Scientists watch your eyes to unlock secrets of vision
Knowledge-focused By invitation onlyThis study looks at how the brain handles visual information by measuring eye movements in healthy adults. Researchers will show images on a screen and track participants' eye movements using a special camera. The goal is to better understand normal vision, not to treat any disea…
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Groundbreaking study could unlock early detection of vision issues in infants
Knowledge-focused By invitation onlyThis study is working to create a simple screening test to find cerebral vision impairment (CVI) in babies and young children. CVI is a leading cause of vision problems in kids, often linked to brain injuries or conditions. Researchers will study 600 children to better understand…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Cochlear implant study tracks hearing and balance over two years
Knowledge-focused OngoingThis study follows 39 adults with severe hearing loss who are getting a cochlear implant. Researchers will test their hearing and balance at several points over two years, using both objective tests and patient questionnaires. The goal is to better understand how the implant affe…
Sponsor: Aalborg University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Ambulance access study aims to make maternity care fairer for all
Knowledge-focused OngoingThis study looks at whether women from different backgrounds have equal access to ambulance services during pregnancy, birth, and after having a baby. Researchers will analyze data from 18,000 women in Manchester, UK, comparing those who used an ambulance with those who didn't, a…
Sponsor: Manchester University NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can't name your feelings? it might make your migraines worse
Knowledge-focused By invitation onlyThis study looks at whether alexithymia—trouble recognizing or describing emotions—is linked to how often women get migraines. Researchers will track 350 female migraine patients aged 12-65 using questionnaires. The goal is to understand if emotional awareness affects migraine se…
Sponsor: Azienda Sanitaria Locale di Alessandria • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can your diet and habits protect your eyes? new study investigates AMD risk factors
Knowledge-focused OngoingThis study is looking at how genetics, diet, lifestyle, and medications work together to influence the risk of age-related macular degeneration (AMD), a leading cause of vision loss. Researchers will collect blood samples and health information from 1,800 adults in Portugal. The …
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
ACL pain study pulled before it even started
Knowledge-focused CancelledThis study aimed to see if adding dry needling and soft tissue massage to standard care could reduce pain and the need for painkillers after ACL reconstruction. It planned to follow patients for four weeks after surgery. However, the study was withdrawn before enrolling any parti…
Sponsor: Keller Army Community Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New eye test could spot Blindness-Causing diseases years earlier
Knowledge-focused By invitation onlyThis study is testing a special eye test called microperimetry to see if it can detect early signs of dry age-related macular degeneration and diabetic retinopathy. Researchers will measure how sensitive the central retina is to light and compare it with standard scans. The goal …
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:41 UTC
-
Real-World epilepsy study tracks Add-On drug effectiveness
Knowledge-focused OngoingThis study follows 300 adults with focal epilepsy who are starting an additional anti-seizure medication (ASM) alongside their current treatment. Researchers will track changes in seizure frequency and quality of life over 12 months in everyday clinical settings. The goal is to s…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:45 UTC
-
Seizure-Detecting wearable study pulled before it began
Knowledge-focused CancelledThis study planned to test a wearable device called EpiCare@Home that records brain activity, heart rate, and movement to detect focal seizures. It was designed for people with epilepsy, both in the hospital and at home. However, the study was withdrawn before enrolling any parti…
Sponsor: Byteflies • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:17 UTC
-
Study reveals top eye diseases behind vision disability in upper egypt
Knowledge-focused OngoingThis study reviews the medical records of 2,000 people in Upper Egypt who applied for visual disability certification between 2020 and 2024. Researchers will analyze eye exams and tests to find the most common diseases causing severe vision loss. The goal is to understand which c…
Sponsor: New Valley University • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:54 UTC